Symbol:
Trio
Name:
trio Rho guanine nucleotide exchange factor
RGD ID:
1308360
Description:
Enables enzyme binding activity. Involved in modulation of chemical synaptic transmission. Is active in Schaffer collateral - CA1 synapse; glutamatergic synapse; and postsynapse. Human ortholog(s) of this gene implicated in autosomal dominant intellectual developmental disorder 44 and autosomal dominant intellectual developmental disorder 63 with macrocephaly. Orthologous to human TRIO (trio Rho guanine nucleotide exchange factor); INTERACTS WITH 17alpha-ethynylestradiol; 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC310192; triple functional domain (PTPRF interacting); triple functional domain protein
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 2 80,235,485 - 80,531,824 (-) NCBI GRCr8 mRatBN7.2 2 78,505,069 - 78,801,384 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 2 78,505,070 - 78,803,135 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 2 85,573,060 - 85,868,316 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 2 83,694,791 - 83,990,060 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 2 78,761,319 - 79,056,786 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 2 80,471,398 - 80,769,313 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 80,473,202 - 80,667,481 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 2 100,137,355 - 100,437,964 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 2 79,634,843 - 79,832,549 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 2 79,581,604 - 79,878,530 (-) NCBI Celera 2 74,141,588 - 74,436,556 (-) NCBI Celera Cytogenetic Map 2 q22 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Trio Rat (-)-demecolcine increases expression ISO TRIO (Homo sapiens) 6480464 Demecolcine results in increased expression of TRIO mRNA CTD PMID:23649840 Trio Rat 1,2-dichloroethane increases expression ISO TRIO (Homo sapiens) 6480464 ethylene dichloride results in increased expression of TRIO mRNA alternative form CTD PMID:37028497 Trio Rat 1,2-dimethylhydrazine decreases expression ISO Trio (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of TRIO mRNA CTD PMID:22206623 Trio Rat 1,2-dimethylhydrazine multiple interactions ISO Trio (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TRIO mRNA CTD PMID:22206623 Trio Rat 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of TRIO mRNA CTD PMID:17557909 Trio Rat 17beta-estradiol decreases expression ISO TRIO (Homo sapiens) 6480464 Estradiol results in decreased expression of TRIO mRNA CTD PMID:21795739 Trio Rat 17beta-estradiol increases expression ISO TRIO (Homo sapiens) 6480464 Estradiol results in increased expression of TRIO mRNA CTD PMID:31614463 Trio Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of TRIO mRNA CTD PMID:32145629 Trio Rat 17beta-estradiol affects expression ISO TRIO (Homo sapiens) 6480464 Estradiol affects the expression of TRIO mRNA CTD PMID:22574217 Trio Rat 17beta-estradiol multiple interactions ISO TRIO (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of TRIO mRNA and [Parathion co-treated with Estradiol] results in increased expression of TRIO protein CTD PMID:17622325 and PMID:30165855 Trio Rat 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO TRIO (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of TRIO mRNA CTD PMID:29581250 Trio Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Trio (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of TRIO gene CTD PMID:21212295 Trio Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TRIO mRNA CTD PMID:21215274 and PMID:32109520 Trio Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TRIO mRNA CTD PMID:22298810 Trio Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO TRIO (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of TRIO mRNA CTD PMID:21296121 Trio Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Trio (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of TRIO mRNA CTD PMID:19465110 Trio Rat 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 Trio Rat 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of TRIO mRNA CTD PMID:21346803 Trio Rat 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of TRIO mRNA CTD PMID:21346803 Trio Rat 2-methylcholine affects expression ISO TRIO (Homo sapiens) 6480464 beta-methylcholine affects the expression of TRIO mRNA CTD PMID:21179406 Trio Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO TRIO (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRIO mRNA CTD PMID:28628672 Trio Rat 4,4'-sulfonyldiphenol increases methylation ISO TRIO (Homo sapiens) 6480464 bisphenol S results in increased methylation of TRIO gene CTD PMID:31601247 Trio Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TRIO mRNA CTD PMID:36041667 Trio Rat 4-hydroxyphenyl retinamide decreases expression ISO Trio (Mus musculus) 6480464 Fenretinide results in decreased expression of TRIO mRNA CTD PMID:28973697 Trio Rat acrolein multiple interactions ISO TRIO (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of TRIO mRNA more ... CTD PMID:32699268 and PMID:32845096 Trio Rat aflatoxin B1 decreases methylation ISO TRIO (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of TRIO intron CTD PMID:30157460 Trio Rat Aflatoxin B2 alpha affects methylation ISO TRIO (Homo sapiens) 6480464 aflatoxin B2 affects the methylation of TRIO intron CTD PMID:30157460 Trio Rat all-trans-retinoic acid decreases expression ISO TRIO (Homo sapiens) 6480464 Tretinoin results in decreased expression of TRIO mRNA CTD PMID:15498508 Trio Rat all-trans-retinoic acid increases expression ISO TRIO (Homo sapiens) 6480464 Tretinoin results in increased expression of TRIO mRNA CTD PMID:23724009 Trio Rat alpha-pinene multiple interactions ISO TRIO (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of TRIO mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of TRIO mRNA CTD PMID:32699268 Trio Rat amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of TRIO mRNA CTD PMID:38685447 Trio Rat amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of TRIO mRNA CTD PMID:30779732 Trio Rat antirheumatic drug increases expression ISO TRIO (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of TRIO mRNA CTD PMID:24449571 Trio Rat aristolochic acid A decreases expression ISO TRIO (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of TRIO mRNA CTD PMID:33212167 Trio Rat arsenite(3-) multiple interactions ISO TRIO (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to TRIO mRNA] CTD PMID:32406909 Trio Rat atropine multiple interactions ISO TRIO (Homo sapiens) 6480464 Atropine inhibits the reaction [Parathion results in increased expression of TRIO protein] CTD PMID:17390078 Trio Rat benzo[a]pyrene decreases expression ISO Trio (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of TRIO mRNA CTD PMID:19770486 Trio Rat benzo[a]pyrene increases methylation ISO Trio (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of TRIO intron CTD PMID:27901495 Trio Rat benzo[a]pyrene affects methylation ISO TRIO (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of TRIO intron CTD PMID:30157460 Trio Rat benzo[a]pyrene increases methylation ISO TRIO (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of TRIO promoter CTD PMID:27901495 Trio Rat benzo[a]pyrene decreases expression ISO TRIO (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of TRIO mRNA CTD PMID:20064835 more ... Trio Rat benzo[a]pyrene diol epoxide I decreases expression ISO TRIO (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20018196 Trio Rat benzo[e]pyrene affects methylation ISO TRIO (Homo sapiens) 6480464 benzo(e)pyrene affects the methylation of TRIO intron CTD PMID:30157460 Trio Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TRIO mRNA CTD PMID:30816183 and PMID:32145629 Trio Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TRIO mRNA CTD PMID:36041667 Trio Rat bisphenol A increases methylation ISO TRIO (Homo sapiens) 6480464 bisphenol A results in increased methylation of TRIO gene CTD PMID:31601247 Trio Rat bisphenol A multiple interactions ISO TRIO (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRIO mRNA CTD PMID:28628672 Trio Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TRIO mRNA CTD PMID:36041667 Trio Rat bortezomib decreases expression ISO TRIO (Homo sapiens) 6480464 Bortezomib results in decreased expression of TRIO mRNA CTD PMID:20977926 Trio Rat C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of TRIO mRNA CTD PMID:19167457 Trio Rat cadmium dichloride increases expression ISO TRIO (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of TRIO mRNA CTD PMID:26472689 and PMID:38382870 Trio Rat caffeine affects phosphorylation ISO TRIO (Homo sapiens) 6480464 Caffeine affects the phosphorylation of TRIO protein CTD PMID:35688186 Trio Rat casticin increases expression ISO Trio (Mus musculus) 6480464 casticin results in increased expression of TRIO mRNA CTD PMID:28444820 Trio Rat CGP 52608 multiple interactions ISO TRIO (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to TRIO gene] CTD PMID:28238834 Trio Rat chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of TRIO mRNA CTD PMID:23125180 Trio Rat chlorpyrifos decreases expression ISO Trio (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of TRIO mRNA CTD PMID:37019170 Trio Rat choline multiple interactions ISO Trio (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TRIO gene CTD PMID:20938992 Trio Rat cisplatin decreases expression ISO TRIO (Homo sapiens) 6480464 Cisplatin results in decreased expression of TRIO mRNA CTD PMID:27392435 Trio Rat cisplatin multiple interactions ISO TRIO (Homo sapiens) 6480464 Cisplatin promotes the reaction [jinfukang results in decreased expression of TRIO mRNA] and jinfukang promotes the reaction [Cisplatin results in decreased expression of TRIO mRNA] CTD PMID:27392435 Trio Rat clobetasol decreases expression ISO Trio (Mus musculus) 6480464 Clobetasol results in decreased expression of TRIO mRNA CTD PMID:27462272 Trio Rat copper(II) sulfate increases expression ISO TRIO (Homo sapiens) 6480464 Copper Sulfate results in increased expression of TRIO mRNA CTD PMID:19549813 Trio Rat coumarin increases phosphorylation ISO TRIO (Homo sapiens) 6480464 coumarin results in increased phosphorylation of TRIO protein CTD PMID:35688186 Trio Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of TRIO mRNA CTD PMID:27523638 Trio Rat cyclosporin A increases expression ISO TRIO (Homo sapiens) 6480464 Cyclosporine results in increased expression of TRIO mRNA CTD PMID:20106945 Trio Rat dexamethasone multiple interactions ISO TRIO (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRIO mRNA CTD PMID:28628672 Trio Rat dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of TRIO mRNA CTD PMID:24893172 Trio Rat dicrotophos increases expression ISO TRIO (Homo sapiens) 6480464 dicrotophos results in increased expression of TRIO mRNA CTD PMID:28302478 Trio Rat dimethylarsinous acid increases expression ISO TRIO (Homo sapiens) 6480464 dimethylarsinous acid results in increased expression of TRIO mRNA CTD PMID:23487506 Trio Rat dioxygen increases expression ISO Trio (Mus musculus) 6480464 Oxygen deficiency results in increased expression of TRIO mRNA CTD PMID:24205000 Trio Rat dorsomorphin multiple interactions ISO TRIO (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIO mRNA CTD PMID:27188386 Trio Rat ethanol multiple interactions ISO Trio (Mus musculus) 6480464 Ethanol affects the expression of and affects the splicing of TRIO mRNA CTD PMID:30319688 Trio Rat fenthion decreases expression ISO Trio (Mus musculus) 6480464 Fenthion results in decreased expression of TRIO mRNA CTD PMID:34813904 Trio Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of TRIO mRNA CTD PMID:24136188 Trio Rat folic acid multiple interactions ISO Trio (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 Trio Rat folic acid decreases expression ISO Trio (Mus musculus) 6480464 Folic Acid results in decreased expression of TRIO mRNA CTD PMID:25629700 Trio Rat FR900359 affects phosphorylation ISO TRIO (Homo sapiens) 6480464 FR900359 affects the phosphorylation of TRIO protein CTD PMID:37730182 Trio Rat hydrogen peroxide decreases expression ISO TRIO (Homo sapiens) 6480464 Hydrogen Peroxide results in decreased expression of TRIO mRNA CTD PMID:18951874 Trio Rat indometacin multiple interactions ISO TRIO (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TRIO mRNA CTD PMID:28628672 Trio Rat ivermectin decreases expression ISO TRIO (Homo sapiens) 6480464 Ivermectin results in decreased expression of TRIO protein CTD PMID:32959892 Trio Rat L-methionine multiple interactions ISO Trio (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TRIO gene CTD PMID:20938992 Trio Rat lead(0) decreases expression ISO TRIO (Homo sapiens) 6480464 Lead results in decreased expression of TRIO mRNA CTD PMID:19921347 Trio Rat lipopolysaccharide multiple interactions ISO Trio (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of TRIO gene CTD PMID:21212295 Trio Rat methapyrilene affects methylation ISO TRIO (Homo sapiens) 6480464 Methapyrilene affects the methylation of TRIO intron CTD PMID:30157460 Trio Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of TRIO gene CTD PMID:35440735 Trio Rat methylmercury chloride increases expression ISO TRIO (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of TRIO mRNA CTD PMID:23179753 more ... Trio Rat N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] affects the methylation of TRIO gene CTD PMID:33148267 Trio Rat nickel dichloride increases expression ISO TRIO (Homo sapiens) 6480464 nickel chloride results in increased expression of TRIO mRNA CTD PMID:17312168 Trio Rat nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of TRIO mRNA CTD PMID:22110744 Trio Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] affects the expression of TRIO mRNA CTD PMID:25729387 Trio Rat ozone multiple interactions ISO TRIO (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of TRIO mRNA more ... CTD PMID:32699268 and PMID:32845096 Trio Rat paracetamol increases expression ISO TRIO (Homo sapiens) 6480464 Acetaminophen results in increased expression of TRIO mRNA CTD PMID:29067470 Trio Rat parathion multiple interactions ISO TRIO (Homo sapiens) 6480464 [Parathion co-treated with Estradiol] results in increased expression of TRIO protein and Atropine inhibits the reaction [Parathion results in increased expression of TRIO protein] CTD PMID:17390078 and PMID:17622325 Trio Rat parathion increases expression ISO TRIO (Homo sapiens) 6480464 Parathion results in increased expression of TRIO protein CTD PMID:17390078 and PMID:17622325 Trio Rat permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] affects the methylation of TRIO gene CTD PMID:33148267 Trio Rat phenobarbital affects methylation ISO Trio (Mus musculus) 6480464 Phenobarbital affects the methylation of TRIO gene CTD PMID:19233941 Trio Rat phenylmercury acetate increases expression ISO TRIO (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of TRIO mRNA CTD PMID:26272509 Trio Rat phenylmercury acetate multiple interactions ISO TRIO (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIO mRNA CTD PMID:27188386 Trio Rat pirinixic acid increases expression ISO Trio (Mus musculus) 6480464 pirinixic acid results in increased expression of TRIO mRNA CTD PMID:17426115 Trio Rat potassium dichromate decreases expression ISO TRIO (Homo sapiens) 6480464 Potassium Dichromate results in decreased expression of TRIO protein CTD PMID:23718831 Trio Rat resveratrol multiple interactions ISO Trio (Mus musculus) 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of TRIO mRNA] CTD PMID:31298478 Trio Rat SB 431542 multiple interactions ISO TRIO (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIO mRNA CTD PMID:27188386 Trio Rat silver atom decreases expression ISO Trio (Mus musculus) 6480464 Silver results in decreased expression of TRIO mRNA CTD PMID:27131904 Trio Rat silver(0) decreases expression ISO Trio (Mus musculus) 6480464 Silver results in decreased expression of TRIO mRNA CTD PMID:27131904 Trio Rat sodium arsenate decreases expression ISO Trio (Mus musculus) 6480464 sodium arsenate results in decreased expression of TRIO mRNA CTD PMID:21795629 Trio Rat sodium arsenate increases expression ISO Trio (Mus musculus) 6480464 sodium arsenate results in increased expression of TRIO mRNA CTD PMID:21795629 Trio Rat sodium arsenite increases expression ISO TRIO (Homo sapiens) 6480464 sodium arsenite results in increased expression of TRIO mRNA CTD PMID:38568856 Trio Rat tamibarotene affects expression ISO TRIO (Homo sapiens) 6480464 tamibarotene affects the expression of TRIO mRNA CTD PMID:15498508 Trio Rat tert-butyl hydroperoxide increases expression ISO TRIO (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of TRIO mRNA CTD PMID:15336504 Trio Rat thiram increases expression ISO TRIO (Homo sapiens) 6480464 Thiram results in increased expression of TRIO mRNA CTD PMID:38568856 Trio Rat titanium dioxide multiple interactions ISO Trio (Mus musculus) 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of TRIO mRNA] CTD PMID:31298478 Trio Rat titanium dioxide decreases methylation ISO Trio (Mus musculus) 6480464 titanium dioxide results in decreased methylation of TRIO gene CTD PMID:35295148 Trio Rat titanium dioxide increases methylation ISO Trio (Mus musculus) 6480464 titanium dioxide results in increased methylation of TRIO gene CTD PMID:35295148 Trio Rat titanium dioxide increases expression ISO Trio (Mus musculus) 6480464 titanium dioxide results in increased expression of TRIO mRNA CTD PMID:31298478 Trio Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] affects the expression of TRIO mRNA CTD PMID:25729387 Trio Rat trichostatin A increases expression ISO TRIO (Homo sapiens) 6480464 trichostatin A results in increased expression of TRIO mRNA CTD PMID:24935251 and PMID:26272509 Trio Rat triphenyl phosphate affects expression ISO TRIO (Homo sapiens) 6480464 triphenyl phosphate affects the expression of TRIO mRNA CTD PMID:37042841 Trio Rat triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of TRIO mRNA CTD PMID:30589522 Trio Rat troglitazone decreases expression ISO Trio (Mus musculus) 6480464 troglitazone results in decreased expression of TRIO mRNA CTD PMID:28973697 Trio Rat tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate multiple interactions ISO TRIO (Homo sapiens) 6480464 Atropine inhibits the reaction [Parathion results in increased expression of TRIO protein] CTD PMID:17390078 Trio Rat valproic acid decreases methylation ISO TRIO (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of TRIO gene CTD PMID:29154799 Trio Rat valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of TRIO mRNA CTD PMID:29427782 Trio Rat vincristine increases expression ISO TRIO (Homo sapiens) 6480464 Vincristine results in increased expression of TRIO mRNA CTD PMID:23649840
(-)-demecolcine (ISO) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (EXP) 17beta-estradiol (EXP,ISO) 17beta-hydroxy-5alpha-androstan-3-one (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (EXP) 2,4-dinitrotoluene (EXP) 2,6-dinitrotoluene (EXP) 2-methylcholine (ISO) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-sulfonyldiphenol (EXP,ISO) 4-hydroxyphenyl retinamide (ISO) acrolein (ISO) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) all-trans-retinoic acid (ISO) alpha-pinene (ISO) amitrole (EXP) amphetamine (EXP) antirheumatic drug (ISO) aristolochic acid A (ISO) arsenite(3-) (ISO) atropine (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) benzo[e]pyrene (ISO) bisphenol A (EXP,ISO) bisphenol F (EXP) bortezomib (ISO) C60 fullerene (EXP) cadmium dichloride (ISO) caffeine (ISO) casticin (ISO) CGP 52608 (ISO) chloroprene (EXP) chlorpyrifos (ISO) choline (ISO) cisplatin (ISO) clobetasol (ISO) copper(II) sulfate (ISO) coumarin (ISO) Cuprizon (EXP) cyclosporin A (ISO) dexamethasone (ISO) dibutyl phthalate (EXP) dicrotophos (ISO) dimethylarsinous acid (ISO) dioxygen (ISO) dorsomorphin (ISO) ethanol (ISO) fenthion (ISO) flutamide (EXP) folic acid (ISO) FR900359 (ISO) hydrogen peroxide (ISO) indometacin (ISO) ivermectin (ISO) L-methionine (ISO) lead(0) (ISO) lipopolysaccharide (ISO) methapyrilene (ISO) methoxychlor (EXP) methylmercury chloride (ISO) N,N-diethyl-m-toluamide (EXP) nickel dichloride (EXP,ISO) oxaliplatin (EXP) ozone (ISO) paracetamol (ISO) parathion (ISO) permethrin (EXP) phenobarbital (ISO) phenylmercury acetate (ISO) pirinixic acid (ISO) potassium dichromate (ISO) resveratrol (ISO) SB 431542 (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenate (ISO) sodium arsenite (ISO) tamibarotene (ISO) tert-butyl hydroperoxide (ISO) thiram (ISO) titanium dioxide (ISO) topotecan (EXP) trichostatin A (ISO) triphenyl phosphate (EXP,ISO) troglitazone (ISO) tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate (ISO) valproic acid (EXP,ISO) vincristine (ISO)
Cellular Component
cell projection (IEA) cytoplasm (IBA,IEA) extrinsic component of membrane (IBA) glutamatergic synapse (IDA,IEA,IEP,IMP,ISO) postsynapse (IDA,IEA,IEP,IMP) presynaptic active zone (IEA,ISO) Schaffer collateral - CA1 synapse (IDA,IMP)
1.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
2.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
3.
Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP.
Herring BE and Nicoll RA, Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2264-9. doi: 10.1073/pnas.1600179113. Epub 2016 Feb 8.
4.
Synaptic Kalirin-7 and Trio Interactomes Reveal a GEF Protein-Dependent Neuroligin-1 Mechanism of Action.
Paskus JD, etal., Cell Rep. 2019 Dec 3;29(10):2944-2952.e5. doi: 10.1016/j.celrep.2019.10.115.
5.
GOA pipeline
RGD automated data pipeline
6.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
7.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
8.
Trio, a Rho Family GEF, Interacts with the Presynaptic Active Zone Proteins Piccolo and Bassoon.
Terry-Lorenzo RT, etal., PLoS One. 2016 Dec 1;11(12):e0167535. doi: 10.1371/journal.pone.0167535. eCollection 2016.
9.
Cdk5 and Trio modulate endocrine cell exocytosis.
Xin X, etal., J Cell Sci. 2004 Sep 15;117(Pt 20):4739-48. Epub 2004 Aug 25.
Trio (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 2 80,235,485 - 80,531,824 (-) NCBI GRCr8 mRatBN7.2 2 78,505,069 - 78,801,384 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 2 78,505,070 - 78,803,135 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 2 85,573,060 - 85,868,316 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 2 83,694,791 - 83,990,060 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 2 78,761,319 - 79,056,786 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 2 80,471,398 - 80,769,313 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 80,473,202 - 80,667,481 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 2 100,137,355 - 100,437,964 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 2 79,634,843 - 79,832,549 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 2 79,581,604 - 79,878,530 (-) NCBI Celera 2 74,141,588 - 74,436,556 (-) NCBI Celera Cytogenetic Map 2 q22 NCBI
TRIO (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 5 14,143,342 - 14,510,204 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 5 14,143,342 - 14,532,128 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 5 14,143,451 - 14,510,313 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 5 14,196,829 - 14,562,458 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 5 14,196,828 - 14,562,457 NCBI Celera 5 14,168,142 - 14,532,209 (+) NCBI Celera Cytogenetic Map 5 p15.2 NCBI HuRef 5 14,242,473 - 14,481,695 (+) NCBI HuRef CHM1_1 5 14,143,936 - 14,509,323 (+) NCBI CHM1_1 T2T-CHM13v2.0 5 14,080,499 - 14,449,245 (+) NCBI T2T-CHM13v2.0
Trio (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 15 27,730,735 - 28,025,954 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 15 27,730,737 - 28,025,934 (-) Ensembl GRCm39 Ensembl GRCm38 15 27,730,649 - 28,025,848 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 15 27,730,651 - 28,025,848 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 15 27,660,404 - 27,955,603 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 15 27,675,376 - 27,970,437 (-) NCBI MGSCv36 mm8 Celera 15 28,478,779 - 28,774,257 (-) NCBI Celera Cytogenetic Map 15 B1 NCBI cM Map 15 10.4 NCBI
Trio (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955426 3,646,728 - 3,846,988 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955426 3,647,273 - 3,846,916 (+) NCBI ChiLan1.0 ChiLan1.0
TRIO (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 4 14,378,176 - 14,744,826 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 5 12,531,783 - 12,898,436 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 5 14,448,259 - 14,814,875 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 5 14,417,910 - 14,655,906 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 5 14,423,780 - 14,654,124 (+) Ensembl panpan1.1 panPan2
TRIO (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 34 271,572 - 505,656 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 34 272,290 - 505,636 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 34 4,764,923 - 5,120,561 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 34 182,486 - 534,192 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 34 220,773 - 415,767 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 34 194,569 - 548,163 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 34 194,407 - 546,539 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 34 437,086 - 788,757 (-) NCBI UU_Cfam_GSD_1.0
Trio (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024407213 233,228,026 - 233,436,351 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936665 1,821,583 - 2,030,371 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936665 1,821,580 - 2,029,839 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
TRIO (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 16 3,564,171 - 3,921,553 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 16 3,690,831 - 3,921,554 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 16 4,216,390 - 4,261,443 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
TRIO (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 4 13,846,753 - 14,214,647 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 4 13,847,936 - 14,215,164 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666064 14,316,908 - 14,686,030 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Trio (Heterocephalus glaber - naked mole-rat)
.
Assembly: Rnor_5.0
Assembly: Rnor_6.0
Predicted Target Of
Count of predictions: 38 Count of miRNA genes: 37 Interacting mature miRNAs: 37 Transcripts: ENSRNOT00000016784, ENSRNOT00000049793 Prediction methods: Miranda, Rnahybrid Result types: miRGate_prediction
1578777 Stresp15 Stress response QTL 15 2 0.05 blood aldosterone amount (VT:0005346) plasma aldosterone level (CMO:0000551) 2 59846005 104846005 Rat 2293671 Bss44 Bone structure and strength QTL 44 10.97 0.0001 lumbar vertebra morphology trait (VT:0010494) lumbar vertebra cortical cross-sectional area (CMO:0001690) 2 43162366 148478373 Rat 1298074 Bp164 Blood pressure QTL 164 0.003 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 42804607 202447032 Rat 1354648 Bp239 Blood pressure QTL 239 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 66118463 226797303 Rat 2293676 Bmd19 Bone mineral density QTL 19 10.7 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 2 43162366 111362592 Rat 10755499 Bp389 Blood pressure QTL 389 2.61 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 18960362 228801039 Rat 2293682 Bmd24 Bone mineral density QTL 24 8.9 0.0001 femur mineral mass (VT:0010011) compact volumetric bone mineral density (CMO:0001730) 2 43162366 111362592 Rat 152025242 Bw191 Body weight QTL 191 3.62 body mass (VT:0001259) 2 38573329 122609194 Rat 631198 Cm22 Cardiac mass QTL 22 4.3 0.0008 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 2 76539322 150540526 Rat 1302794 Stl27 Serum triglyceride level QTL 27 4.4 0.0001 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 2 25413423 143657569 Rat 61465 Bp13 Blood pressure QTL 13 3.3 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 2 76539322 102785628 Rat 1581569 Uae32 Urinary albumin excretion QTL 32 0.0001 urine protein amount (VT:0005160) urine albumin excretion rate (CMO:0000757) 2 78665619 219826953 Rat 61467 Bp14 Blood pressure QTL 14 2.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 43154682 202446871 Rat 70174 BpQTLCluster2 Blood pressure QTL cluster 2 4.24 arterial blood pressure trait (VT:2000000) absolute change in mean arterial blood pressure (CMO:0000533) 2 40067944 102785628 Rat 1358901 Cm38 Cardiac mass QTL 38 2 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 157142209 Rat 631208 Bw1 Body weight QTL1 5.09 mesenteric fat pad mass (VT:0010427) mesenteric fat pad weight to body weight ratio (CMO:0000654) 2 43171017 83575226 Rat 1331760 Bp206 Blood pressure QTL 206 3.62454 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 56043031 202447032 Rat 1358899 Kidm23 Kidney mass QTL 23 3.88 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1358908 Bw49 Body weight QTL 49 3.36 body mass (VT:0001259) body weight (CMO:0000012) 2 25413652 157142078 Rat 5684990 Bmd82 Bone mineral density QTL 82 2.8 tibia mineral mass (VT:1000283) bone mineral content (CMO:0001554) 2 59324377 103795077 Rat 1358910 Kidm27 Kidney mass QTL 27 5.77 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 61355 Bp36 Blood pressure QTL 36 2.9 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 2 5873687 102844969 Rat 1358911 Kidm28 Kidney mass QTL 28 5.42 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1358904 Cm39 Cardiac mass QTL 39 2.26 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 157142209 Rat 7411551 Bw131 Body weight QTL 131 29.6 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 2 67942638 112942638 Rat 1359034 Bp274 Blood pressure QTL 274 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 74786664 94359546 Rat 1358887 Bw50 Body weight QTL 50 2.39 body mass (VT:0001259) body weight (CMO:0000012) 2 25413652 157142078 Rat 1298080 Bp163 Blood pressure QTL 163 0.02 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 66118275 202447032 Rat 1298085 Bp165 Blood pressure QTL 165 0.0006 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 42804607 202447032 Rat 2290453 Scl55 Serum cholesterol level QTL 55 2.83 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 2 26917817 136917119 Rat 2299162 Iddm32 Insulin dependent diabetes mellitus QTL 32 2.36 blood glucose amount (VT:0000188) age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) 2 78665616 143657569 Rat 1358894 Kidm24 Kidney mass QTL 24 4.03 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 61371 Edpm1 Estrogen-dependent pituitary mass QTL 1 4 0.05 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 2 35134841 88029593 Rat 724534 Uae6 Urinary albumin excretion QTL 6 10 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 2 78665619 249053267 Rat 61374 Edpm2 Estrogen-dependent pituitary mass QTL 2 4.42 0.86 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 2 76539322 202447032 Rat 631500 Bp99 Blood pressure QTL 99 2.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 59324719 102755241 Rat 10755436 Coatc8 Coat color QTL 8 0.02431 coat/hair pigmentation trait (VT:0010463) pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) 2 35023117 80023117 Rat 1358917 Cm42 Cardiac mass QTL 42 2.82 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 203928301 Rat 5684996 Bmd85 Bone mineral density QTL 85 4.7 0.024 tibia mineral mass (VT:1000283) bone mineral density (CMO:0001226) 2 59324377 103795077 Rat 1358913 Cm41 Cardiac mass QTL 41 2.73 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 203928301 Rat 2293835 Kiddil5 Kidney dilation QTL 5 3.8 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 2 42804607 157142209 Rat 1558653 Prcr1 Prostate cancer resistance QTL 1 5 prostate integrity trait (VT:0010571) area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio (CMO:0000899) 2 72532993 157142209 Rat 631266 Bp132 Blood pressure QTL 132 0.0005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 46123260 202447032 Rat 1354617 Bp240 Blood pressure QTL 240 4 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 26917817 81754745 Rat 1558648 Smcn1 Smooth muscle cell number QTL 1 0.039 blood vessel smooth muscle cell quantity (VT:0010525) aorta smooth muscle cell count per unit vessel length (CMO:0001646) 2 59134147 127460910 Rat 2293843 Kiddil6 Kidney dilation QTL 6 3.1 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 2 42804607 182042367 Rat 2306903 Bp336 Blood pressure QTL 336 0.01 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 64366971 109366971 Rat 152025206 Hrtrt23 Heart rate QTL 23 5.98 heart pumping trait (VT:2000009) 2 28484589 169504100 Rat 1354605 Rf48 Renal function QTL 48 2.9 blood creatinine amount (VT:0005328) plasma creatinine level (CMO:0000537) 2 74786664 206665859 Rat 152025204 Hrtrt22 Heart rate QTL 22 5.6 heart pumping trait (VT:2000009) 2 28484589 169504100 Rat 1354601 Slep1 Serum leptin concentration QTL 1 5.39 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 2 43171017 184114403 Rat 61438 Cia7 Collagen induced arthritis QTL 7 4.6 0.0001 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 2 59324377 141596857 Rat 1354603 Bp243 Blood pressure QTL 243 3.9 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 26917817 127469484 Rat
D2Rat75
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 78,665,616 - 78,665,758 (+) MAPPER mRatBN7.2 Rnor_6.0 2 80,631,950 - 80,632,091 NCBI Rnor6.0 Rnor_5.0 2 100,298,393 - 100,298,534 UniSTS Rnor5.0 RGSC_v3.4 2 79,796,831 - 79,796,972 UniSTS RGSC3.4 RGSC_v3.4 2 79,796,790 - 79,797,113 RGD RGSC3.4 RGSC_v3.1 2 79,741,793 - 79,741,934 RGD Celera 2 74,301,000 - 74,301,141 UniSTS RH 3.4 Map 2 396.9 RGD RH 3.4 Map 2 396.9 UniSTS RH 2.0 Map 2 399.9 RGD SHRSP x BN Map 2 30.8998 RGD FHH x ACI Map 2 36.4899 RGD Cytogenetic Map 2 q22 UniSTS
D2Mco18
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 2 80,396,034 - 80,396,178 (+) Marker Load Pipeline mRatBN7.2 2 78,665,619 - 78,665,763 (+) MAPPER mRatBN7.2 Rnor_6.0 2 80,631,953 - 80,632,096 NCBI Rnor6.0 Rnor_5.0 2 100,298,396 - 100,298,539 UniSTS Rnor5.0 RGSC_v3.4 2 79,796,833 - 79,796,977 RGD RGSC3.4 RGSC_v3.4 2 79,796,834 - 79,796,977 UniSTS RGSC3.4 RGSC_v3.1 2 79,741,795 - 79,741,939 RGD Celera 2 74,301,003 - 74,301,146 UniSTS Cytogenetic Map 2 q22 UniSTS
D2Chm172
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 2 80,524,744 - 80,524,990 (+) Marker Load Pipeline mRatBN7.2 2 78,794,334 - 78,794,584 (+) MAPPER mRatBN7.2 Rnor_6.0 2 80,762,019 - 80,762,268 NCBI Rnor6.0 Rnor_5.0 2 100,429,269 - 100,429,518 UniSTS Rnor5.0 RGSC_v3.4 2 79,927,091 - 79,927,340 UniSTS RGSC3.4 Celera 2 74,429,947 - 74,430,196 UniSTS Cytogenetic Map 2 q22 UniSTS
D2Got381
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 78,580,439 - 78,580,561 (+) MAPPER mRatBN7.2 Rnor_6.0 2 80,546,796 - 80,546,915 NCBI Rnor6.0 Rnor_5.0 2 100,213,239 - 100,213,358 UniSTS Rnor5.0 RGSC_v3.4 2 79,711,313 - 79,711,432 UniSTS RGSC3.4 Celera 2 74,215,838 - 74,215,957 UniSTS Cytogenetic Map 2 q22 UniSTS
RH144049
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 78,532,627 - 78,532,748 (+) MAPPER mRatBN7.2 Rnor_6.0 2 80,498,950 - 80,499,070 NCBI Rnor6.0 Rnor_5.0 2 100,165,624 - 100,165,744 UniSTS Rnor5.0 RGSC_v3.4 2 79,662,694 - 79,662,814 UniSTS RGSC3.4 Celera 2 74,169,077 - 74,169,197 UniSTS RH 3.4 Map 2 395.5 UniSTS Cytogenetic Map 2 q22 UniSTS
RH140371
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 78,505,210 - 78,505,373 (+) MAPPER mRatBN7.2 Rnor_6.0 2 80,471,540 - 80,471,702 NCBI Rnor6.0 Rnor_5.0 2 100,137,497 - 100,137,659 UniSTS Rnor5.0 RGSC_v3.4 2 79,634,981 - 79,635,143 UniSTS RGSC3.4 Celera 2 74,141,730 - 74,141,892 UniSTS Cytogenetic Map 2 q22 UniSTS
RH128153
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 78,505,672 - 78,505,853 (+) MAPPER mRatBN7.2 Rnor_6.0 2 80,472,002 - 80,472,182 NCBI Rnor6.0 Rnor_5.0 2 100,137,959 - 100,138,139 UniSTS Rnor5.0 RGSC_v3.4 2 79,635,443 - 79,635,623 UniSTS RGSC3.4 Celera 2 74,142,192 - 74,142,372 UniSTS Cytogenetic Map 2 q22 UniSTS
RH142794
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 78,506,240 - 78,506,359 (+) MAPPER mRatBN7.2 Rnor_6.0 2 80,472,570 - 80,472,688 NCBI Rnor6.0 Rnor_5.0 2 100,138,527 - 100,138,645 UniSTS Rnor5.0 RGSC_v3.4 2 79,636,011 - 79,636,129 UniSTS RGSC3.4 Celera 2 74,142,760 - 74,142,878 UniSTS RH 3.4 Map 2 394.0 UniSTS Cytogenetic Map 2 q22 UniSTS
RH143590
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 78,618,167 - 78,618,294 (+) MAPPER mRatBN7.2 Rnor_6.0 2 80,584,500 - 80,584,626 NCBI Rnor6.0 Rnor_5.0 2 100,250,943 - 100,251,069 UniSTS Rnor5.0 RGSC_v3.4 2 79,749,381 - 79,749,507 UniSTS RGSC3.4 Celera 2 74,253,556 - 74,253,682 UniSTS RH 3.4 Map 2 396.5 UniSTS Cytogenetic Map 2 q22 UniSTS
RH143835
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 78,774,446 - 78,774,724 (+) MAPPER mRatBN7.2 Rnor_6.0 2 80,742,132 - 80,742,409 NCBI Rnor6.0 Rnor_5.0 2 100,409,382 - 100,409,659 UniSTS Rnor5.0 RGSC_v3.4 2 79,907,204 - 79,907,481 UniSTS RGSC3.4 Celera 2 74,410,032 - 74,410,309 UniSTS RH 3.4 Map 2 397.8 UniSTS Cytogenetic Map 2 q22 UniSTS
BE106322
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 78,698,221 - 78,698,372 (+) MAPPER mRatBN7.2 Rnor_6.0 2 80,665,909 - 80,666,059 NCBI Rnor6.0 Rnor_5.0 2 100,333,159 - 100,333,309 UniSTS Rnor5.0 RGSC_v3.4 2 79,830,981 - 79,831,131 UniSTS RGSC3.4 Celera 2 74,333,391 - 74,333,541 UniSTS RH 3.4 Map 2 396.0 UniSTS Cytogenetic Map 2 q22 UniSTS
BE115314
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 78,544,060 - 78,544,226 (+) MAPPER mRatBN7.2 Rnor_6.0 2 80,510,380 - 80,510,545 NCBI Rnor6.0 Rnor_5.0 2 100,177,054 - 100,177,219 UniSTS Rnor5.0 RGSC_v3.4 2 79,674,062 - 79,674,227 UniSTS RGSC3.4 Celera 2 74,179,449 - 74,179,614 UniSTS RH 3.4 Map 2 397.0 UniSTS Cytogenetic Map 2 q22 UniSTS
RH138486
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 78,513,320 - 78,513,484 (+) MAPPER mRatBN7.2 Rnor_6.0 2 80,479,650 - 80,479,813 NCBI Rnor6.0 Rnor_5.0 2 100,145,607 - 100,145,770 UniSTS Rnor5.0 RGSC_v3.4 2 79,643,091 - 79,643,254 UniSTS RGSC3.4 Celera 2 74,149,840 - 74,150,003 UniSTS RH 3.4 Map 2 385.8 UniSTS Cytogenetic Map 2 q22 UniSTS
RH139536
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 78,505,210 - 78,505,390 (+) MAPPER mRatBN7.2 Rnor_6.0 2 80,471,540 - 80,471,719 NCBI Rnor6.0 Rnor_5.0 2 100,137,497 - 100,137,676 UniSTS Rnor5.0 RGSC_v3.4 2 79,634,981 - 79,635,160 UniSTS RGSC3.4 Celera 2 74,141,730 - 74,141,909 UniSTS RH 3.4 Map 2 394.1 UniSTS Cytogenetic Map 2 q22 UniSTS
BE119929
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 78,611,740 - 78,611,910 (+) MAPPER mRatBN7.2 Rnor_6.0 2 80,578,073 - 80,578,242 NCBI Rnor6.0 Rnor_5.0 2 100,244,516 - 100,244,685 UniSTS Rnor5.0 RGSC_v3.4 2 79,742,954 - 79,743,123 UniSTS RGSC3.4 Celera 2 74,247,129 - 74,247,298 UniSTS RH 3.4 Map 2 394.5 UniSTS Cytogenetic Map 2 q22 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000016784 ⟹ ENSRNOP00000016784
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 2 78,505,070 - 78,699,794 (-) Ensembl Rnor_6.0 Ensembl 2 80,473,202 - 80,667,481 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000093833 ⟹ ENSRNOP00000091530
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 2 78,505,070 - 78,803,135 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000099604 ⟹ ENSRNOP00000081265
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 2 78,545,095 - 78,803,135 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000107418 ⟹ ENSRNOP00000076435
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 2 78,505,070 - 78,803,135 (-) Ensembl
RefSeq Acc Id:
NM_001107658 ⟹ NP_001101128
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 80,235,485 - 80,531,612 (-) NCBI mRatBN7.2 2 78,505,069 - 78,801,207 (-) NCBI
RefSeq Acc Id:
XM_006232090 ⟹ XP_006232152
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 80,235,485 - 80,531,824 (-) NCBI mRatBN7.2 2 78,505,069 - 78,801,384 (-) NCBI Rnor_6.0 2 80,471,398 - 80,769,313 (-) NCBI Rnor_5.0 2 100,137,355 - 100,437,964 (-) NCBI
Sequence:
GAGAATCCTGGCAGGGGGCGCAGTGCCGGCCTGGAAGGCCAGTGTGGGTCGGTCACACTTGTTCCTGCTCCTCCCAGGTTTGGAGCAGCCCTGGAGGAGGAGACCTGGCCAGCTCCACGTTTCTGCAG CCACTCCATTCCGCCCTCAGGGCTCCCAGGCGCGGCCCCGCCCCTCCATGATCCCGCCCACAACAGGCACCGCCCACCAGCCGAGCCCACGCTCCGGCCCCTAACGAAGCTCTCCGGAAATTCCCGAA GCCCCTCTTTTTCCTTCCTCTCCTTTCCCTGCTCTCCCTTTCCTTTCACCCGGACTCCCTCGGCCGTGATTTCTCCCTCCCCCTCCTTCCTTCCCCATCGGAAAGCAAGATGGAGGCTCGCTGCTGCC GCCGGCGTCCGTGATCGCGGAGCTTCTCCAGCCCCGGCCCCCGCCCTCGCGTGTCCGCGCCGCTGCCCGCGCCCCGGCCGGCCACACAGAGGCCGTGGCTCCGCGCGCCCGCCCCGCGCCAGGCTCGC GGTTCCCGGGCGGTGTCCTCGTCTATGTGGGCGCGCTCCTCGGGCCGAGCCGCCGCCGCCCGCCGCCCCGGGGCTGTGCGTCCGCGCGCCGGGCGCGGGCAGCTGGGTGTTCGGCGCCGTCAGGCCAG GCGCGGGCGGCTGGGTGCGCGGAGCTAGGGGCGCGGGGCCTGAGGCGGGCTCGTCCGCCGCCGAAGCCATGAGCGGCAGCAGCGGCGGTGCCACCGCCCCGGCCGCGTCCTCCGGCCCGGCGGCGGCG GCCAGCGCGGCGGGCTCCGGCTGCGGGGGCGGCGCCGGCGAGGGTGCCGAGGAGGCCGCCAAGGACCTGGCCGACATCGCGGCCTTCTTTCGATCCGGGTTTCGAAAAAATGATGAAATGAAAGCTAT GGATGTTTTGCCCATCCTGAAGGAAAAAGTCGCCTACCTTTCAGGTGGCAGAGATAAGCGTGGAGGTCCCATATTAACGTTTCCAGCCCGCAGCAATCATGATAGAATGCGGCAGGAGGACCTCAGGA GGCTCATCTCCTATTTAGCCTGCATTCCCAGCGAGGAAGTCTGCAAGCGAGGGTTCACGGTGATTGTGGACATGCGCGGCTCCAAGTGGGACTCCATCAAACCACTGTTGAAGATCCTGCAGGAGTCC TTCCCCTGCTGCATCCACATCGCCCTGATAATCAAGCCCGACAACTTCTGGCAGAAACAGAGGACGAATTTTGGCAGTTCCAAATTTGAATTTGAGACAAATATGGTCTCTTTAGAAGGCCTTACCAA AGTGGTTGACCCCTCCCAGCTAACCCCTGAGTTTGATGGCTGCCTAGAGTACAACCATGAGGAATGGATAGAAATCCGAGTAGCTTTTGAGGACTACATTAGCAATGCAGCCCACATGCTGTCCCGGC TAGAGGAACTTCAGGACGTCCTTGCAAAAAAGGAGTTACCTCAGGACCTAGAGGGGGCTCGGAACATGATTGACGAGCATTCTCAGCTGAAGAAGAAGGTGATCAAGGCTCCCATCGAGGACTTGGAC TTAGAGGGGCAGAAGCTGCTTCAGCGGATCCAGAGCAGCGAGAGTTTTCCCAAAAAGAACTCAGGCTCGGGCAATGCAGACCTGCAGAACCTCTTGCCCAAGGTGTCCACCATGCTTGACAGGCTGCA CTCGACTCGGCAGCACCTGCACCAGATGTGGCACGTGAGGAAACTGAAGTTGGACCAGTGCTTCCAGCTGCGGCTGTTCGAACAGGATGCTGAGAAGATGTTTGACTGGATCACACACAACAAAGGCC TGTTTCTAAACAGCTACACGGAGATCGGGGCCAGCCACCCTCACGCCATGGAGCTTCAGACGCAGCACAATCACTTTGCTATGAACTGTATGAACGTGTATGTAAATATCAACCGCATAATGTCGGTG GCCAATCGCCTGGTGGAGTCGGGCCACTATGCCTCTCAGCAGATTAAGCAGATCGCCAATCAGCTGGAACAGGAGTGGAAAGCGTTCGCAGCGGCCTTGGACGAGCGCAGCACCTTGTTGGACATGTC CTCCATCTTTCATCAGAAGGCTGAGAAGTACATGAGCAATGTGGACTCGTGGTGTAAGGCCTGTGGTGAAGTAGACCTTCCCTCGGAGCTGCAGGACCTGGAAGATGCCATTCATCATCACCAGGGGA TCTATGAGCACATCACCCTCGCTTACTCTGAGGTAAGCCAGGATGGGAAGTCTCTCCTTGATAAGCTCCAGCGCCCCCTGACCCCCGGCAGCTCTGATTCCCTCACGGCCTCTGCCAACTACTCCAAG GCGGTGCACCATGTCTTGGATGTCATCCACGAGGTCCTGCACCACCAGCGCCAGCTCGAGAACATCTGGCAGCACCGCAAGGTTCGGCTCCACCAGAGGCTGCAGCTCTGTGTCTTCCAGCAGGACGT TCAGCAGGTGCTGGACTGGATAGAGAACCACGGAGAAGCATTTCTGAGCAAACACACAGGCGTGGGCAAATCCCTTCACCGGGCCAGAGCTTTGCAGAAACGCCATGAGGACTTCGAGGAAGTTGCAC AGAACACGTACACAAATGCAGATAAACTGCTAGAAGCAGCAGAGCAGCTGGCTCAGACTGGGGAATGTGACCCCGAAGAGATTTATCAGGCTGCCCATCAGCTTGAAGACCGGATACAAGACTTTGTT CGGCGAGTTGAACAGCGGAAGATCCTGCTGGACATGTCTGTGTCATTTCACACCCATGTAAAAGAGCTCTGGACATGGCTGGAGGAGCTGCAGAAGGAACTGCTGGACGACGTGTACGCCGAGTCGGT GGAGGCCGTCCAGGATCTCATCAAGAGATTCGGCCAGCAGCAGCAGACCACCCTGCAGGTGACAGTCAACGTGATCAAGGAAGGGGAGGACCTCATCCAGCAGCTGAGGGACTCTGCCATCTCCAGTA ACAAGACGCCGCACAACAGCTCCATCAACCACATCGAGACGGTGCTGCAGCAGCTGGACGAGGCTCAGTCCCAGATGGAGGAGCTCTTCCAGGAACGCAAGATCAAGCTGGAACTCTTCCTGCAGCTA CGCATATTCGAGCGGGATGCCATCGACATCATCTCGGACCTTGAGTCTTGGAATGATGAACTTTCCCAGCAAATGAACGACTTCGATACAGAGGATCTGACGATCGCTGAGCAGCGCCTGCAGCACCA TGCGGACAAAGCCCTAACCATGAATAACTTGACTTTCGACGTCATCCACCAGGGACAGGATCTTCTGCAGTACGTCAATGAGGTCCAGGCCTCTGGTGTGGAGCTGCTTTGCGACAGAGATGTGGACA TGGCCACTCGGGTTCAGGACCTCCTGGAGTTTCTTCACGAAAAGCAGCAGGAGTTGGATTTAGCGGCCGAGCAGCATCGGAAACACTTGGAGCAGTGTGTGCAGTTGCGCCACCTGCAGGCAGAAGTG AAGCAGGTACTGGGCTGGATCCGGAATGGAGAGTCCATGCTGAATGCTGGGCTCATCACGGCCAGCTCGCTGCAGGAGGCCGAGCAGCTGCAGAGAGAGCACGAGCAGTTCCAGCACGCTATTGAGAA AACACACCAGAGTGCACTGCAGGTGCAGCAGAAGGCGGAGGCCATGCTGCAGGCCAACCACTACGACATGGACATGATCCGTGACTGTGCAGAGAAGGTCGCCTCGCACTGGCAGCAGCTCATGCTCA AGATGGAAGACCGCCTCAAGCTCGTCAACGCCTCCGTCGCCTTCTACAAGACTTCTGAGCAGGTCTGCAGTGTTCTGGAGAGCCTGGAGCAGGAGTACAAGAGAGAGGAGGACTGGTGTGGTGGAGCC GACAAGCTGGGCCCCAATTCTGAGACTGACCACGTCACCCCAATGATTAGCAAGCACCTCGAACAGAAGGAAGCCTTCCTGAAGGCTTGCACACTGGCCAGGAGGAACGCAGATGTCTTCCTAAAATA CCTACACAGGAACAGCGTGAGCATGCCGGGGATGGTGACACACATCAAAGCTCCAGAACAGCAAGTAAAAAATATCTTGAACGAACTCTTCCAGCGGGAAAACAGGGTATTGCATTATTGGACCATGA GAAAAAGGCGGCTGGACCAGTGCCAGCAGTACGTGGTCTTTGAGAGGAGTGCCAAGCAGGCATTAGAATGGATCCACGACAATGGGGAGTTCTATCTTTCCACACATACCTCAACAGGGTCCAGCATT CAGCATACACAGGAGCTGTTGAAAGAACATGAAGAGTTTCAGATAACTGCCAAGCAAACCAAAGAGAGGGTGAAGCTATTGATACAGCTGGCTGATGGCTTTTGTGAAAAAGGGCATGCCCATGCAGC AGAAATTAAAAAATGTGTGACCGCAGTGGATAAGAGGTACAGAGATTTCTCTCTGCGCATGGAGAAGTACCGGACCTCTTTGGAGAAAGCCCTGGGGATTTCTTCAGATTCCAACAAATCGAGTAAAA GCCTGCAGTTGGACATCATCCCTGCCAGTATCCCCGGGTCAGAGGTGAAGCTTCGGGATGCTGCTCACGAACTCAATGAAGAGAAGCGCAAGTCTGCCCGCAGGAAAGAGTTCATAATGGCTGAGTTA ATTCAAACCGAAAAGGCTTATGTAAGAGACCTTCGAGAATGTATGGATACCTACCTGTGGGAAATGACCAGCGGAGTGGAGGAGATCCCGCCCGGCATCGTCAACAAGGAGCTCATCATCTTCGGGAA CATGCAGGAGATCTACGAGTTCCATAACAACATCTTCCTGAAGGAGCTGGAGAAGTACGAGCAGCTCCCAGAGGACGTGGGGCACTGCTTTGTCACCTGGGCAGACAAGTTTCAGATGTATGTCACAT ACTGCAAAAATAAACCTGATTCTACGCAGCTGATCCTGGAACACGCAGGGTCCTACTTTGACGAGATCCAGCAGCGGCATGGGTTAGCCAATTCCATCTCTTCCTACCTGATCAAACCAGTTCAGCGA ATAACAAAGTACCAGCTCCTTTTAAAAGAGCTGCTCACATGCTGTGAAGAAGGAAAGGGGGAGATTAAAGATGGCCTCGAGGTGATGCTCAGTGTGCCCAAGCGAGCCAATGATGCCATGCACCTCAG CATGCTGGAAGGGTTTGATGAAAACATTGAGTCTCAGGGAGAGCTCATCCTGCAGGAGTCCTTCCAAGTGTGGGACCCAAAAACCTTAATTCGGAAGGGTCGAGAACGCCATCTCTTCCTTTTTGAAA TGTCCTTAGTGTTCAGTAAAGAAGTGAAAGACTCCAGCGGGAGAAGCAAGTACCTGTACAAAAGCAAGCTGTTTACCTCAGAGTTGGGTGTCACGGAACATGTTGAAGGAGATCCTTGCAAATTTGCA CTGTGGGTGGGGAGGACACCAACTTCAGATAATAAAATTGTCCTTAAGGCCTCCAGTATCGAGAACAAACAGGACTGGATAAAGCACATCCGTGAGGTGATACAGGAGAGGACGGTGCACCTGAGAGG AGCCCTGAAGGAGCCCATCCACATCCCCAAGACGGCTCCCGCAGCAAGGCAGAAGGGGAGGAGGGATGGAGAGGACCTGGACAGCCAAGGGGACGGCAGCAGCCAGCCCGACACCATTTCCATTGCCT CCCGGACATCACAGAACACACTGGACAGTGACAAGCTTTCTGGCGGCTGCGAGCTGACAGTGGTGATCCATGACTTCACAGCTTGCAACAGCAATGAGCTGACCATCCGGCGAGGCCAGACAGTGGAG GTTCTCGAACGGCCTCACGACAAGCCCGACTGGTGTCTGGTGCGCACCACTGATAGGTCCCCTGCAGCTGAAGGCCTCGTGCCCTGTGGCTCACTGTGCATTGCCCACTCACGAAGTAGCATGGAGAT GGAGGGCATCTTCAACCACAAAGACTCACTGTCCGTCTCCAGTAATGACGCCAGCCCACCGGCCTCTGTGGCCTCCCTTCAACCCCACATGATGGGAGCACAGAGTTCACCAGGTCCCAAGCGGCCGG GCAACACCCTGCGCAAGTGGCTCACAAGCCCCGTACGGCGGCTCAGCAGTGGCAAGGCCGATGGACATGCGAAGAAGCTGGCCCACAAGCACAAGAAGAGCAGGGAGGTCCGGAAGAGTGCGGACGCT GGATCACAGAAGGATTCAGATGACAGCGCTGCCACCCCACAGGATGAGACCATCGAAGAGAGAGGACGGAACGAGGGCCTCAGCAGTGGTACGCTGTCCAAATCCTCGTCCTCGGGCATGCAGAGCTG CGGAGAAGAAGAAGGAGAGGAGGGCGCCGACGCTGTACCACTGCCTCCGCCCATGGCCATCCAGCAGCACAGCCTCCTTCAGCCAGACTCGCAGGATGACAAGGCCTCTTCGAGGTTATTAGTCCGCC CCACCAGCTCTGAGACTCCCAGTGCGGCTGAGCTCGTCAGTGCGATTGAAGAACTCGTGAAGAGCAAAATGGCGCTGGAGGACCGCCCTAGCTCACTGCTTGTTGACCAGGGAGACAGTAGCAGCCCG TCCTTCAATCCCTCAGACAATTCTCTCCTCTCATCCTCCTCGCCCATTGACGAGATGGAAGAAAGAAAATGCAGCCTCTCTCTAAAGAGAAGACACTATGTTTTGCAAGAATTAGTGGAGACAGAGCG AGACTATGTGCGGGACCTTGGATGTGTGGTTGAGGGCTACATGGCGCTGATGAAGGAAGACGGCGTTCCTGATGACATGAAGGGGAAAGACAAGATCGTGTTTGGCAACATCCATCAGATTTACGACT GGCACAGAGACTTTTTTTTAGGAGAGTTGGAGAAGTGCCTTGAAGATCCAGAAAAACTAGGATCCCTTTTTGTAAAACACGAGAGAAGGTTGCACATGTACATAGTTTATTGTCAAAATAAACCAAAG TCTGAGCACATTGTCTCCGAGTACATCGACACCTTTTTTGAGGACTTAAAGCAGCGCCTGGGCCACAGACTGCAGCTCACTGATCTGTTGATCAAACCTGTGCAGAGAATCATGAAGTACCAGCTGCT CCTGAAGGACTTCCTCAAGTACTCAAAAAAAGCTAGCCTGGACACGTCCGAATTAGAGAAAGCTGTAGAGGTCATGTGCATAGTGCCGAAGCGCTGCAACGACATGATGAACGTCGGGCGGCTGCAAG GATTTGACGGTAAAATTGTTGCCCAGGGTAAACTGCTCTTACAGGACACATTCCTGGTCACAGACCAAGATGCAGGGCTTCTGCCCCGATGCAAAGAGAGGCGGGTTTTCCTCTTTGAACAGATTGTC ATATTCAGCGAACCGCTTGATAAGAAAAAGGGCTTTTCCATGCCAGGATTTCTGTTCAAGAACAGTATCAAGGTGAGTTGCCTTTGCCTGGAGGAGAATGTGGAGAGCGATCCCTGTAAGTTTGCCCT GACATCCAGGACGGGCGATGCCGTGGAGACCTTCATTTTGCATTCATCCAGTCCAAGTGTCCGACAAACGTGGATCCATGAAATCAACCAAATCTTAGAAAACCAGCGCAACTTTTTAAATGCCTTGA CATCACCCATCGAGTACCAGAGGAACCATAGCGGGGGCGGCGGCAGTGGCAGCGGGGGCAGCAGCGGCGGGGGCGGGGGCAGCGGTGGCAGCGGGGCCTCCAGTGGAGGCAGCAGCAGCCATGGCAGT GGCCCCAGCAGCTGCAGCAGTGGCCCCAGCTCGAGCAGGAGCAGGCCCTCCAGGATCCCACAGCCTGTCAGACACCACCCCCCCATGCTGGTCTCCTCTGCAGCCTCAAGCCAGGCAGAGGCAGACAA GATGTCAGGTATGTCTGCTCCCAGCCCCTCACTGCCTACCCCCAGCAACAGCCTGGCCCTCGAGGCCAGCCTTGGCCAGCCCAGCAGGCTCCCCCTGAGTGGAGACTCCGAAGGTCATGAGCGAGAGA CAGAACCCATTCCCAAGATGAAGGTGATGGAGAGCCCCCGGAAGGCCCTGGGGAGTACTTCCGGTACAAGCCAAGATGGAAACACCAAGGATGCCCGGGGGAACCTGGGCCCGCTGCCTCTGGGCAAG ACTAGGCCGGGGGCCGTCTCGCCGCTGAACTCTCCTCTCTCCACCACGTTCCCTTCTCCTTTTGGCAAGGAGGCCTTTCCTCCCAGCAGCCCCCTGCAGAAGGGGGGCTCCTTCTGGAGCTCCATTCC TGCTTCCCCTGCCAGCCGGCCAAGCTCCTTCACCTTCCCGGGGGACAGTGACTCCCTCCAGCGACAGACGCACCGCCATGCAGCCCCCAGCAAGGACACGGACCGCATGAGCACGTGCTCCTCGGCCA GCGAGCAGTCCGTGCAGTCCACTCAGAGCAACGGGAGTGAAAGCAGCAGCAGTAGCAACATCTCCACCATGCTGGTGACACACGAGTACACGGCAGTGAAGGAGGATGAGATAAACGTCTATCAAGGA GAGGTCGTTCAAATTCTGGCCAGCAACCAGCAGAACATGTTTCTGGTGTTCCGAGCCGCCACTGACCAGTGCCCCGCAGCCGAGGGTTGGATTCCAGGCTTCGTCTTGGGCCATACGAGTGCAGTTAT CATGGAGAACCCGGACGGGACTTTCAAGAAGTCAACATCTTGGCACACAGCACTCCGTTTAAGGAAGAAGTCTGAGAAGAAAGATAAAGACGGCAAAAGGGACGGCAAGTTGGAGAACGGGTACAGGA AGCCACGAGAAGGGCTCAGTAACAAGCTTCTCAACCCCAACTATATCTATGACGTTCCCCCAGAATTCGTTATCCCATTGAGCGAGGTCACATGTGAGACAGGGGAGACCGTTGTTTTTAGATGTCGT GTCTGTGGCCGCCCCAAGGCCTCAATCACCTGGAAGGGCCCTGAACACAACACTTTGAACAACGATGACCACTACAACATCTCCTACAGTGACGTTGGGGAGGCCACTCTGAAGATCATTGGTGTGAG CACAGAAGATGATGGTGTCTACACCTGCATCGCTGTGAACGACATGGGTTCAGCCTCGTCTTCTGCCAGTCTGAGGGTTCTAGGTCCAGGGAGTGATGGGATCGTGGTGACCTGGAAGGACAACTTCG ACGCCTTCTACAGTGAGGTGGCTGAGCTCGGCAGGGGCAGATTTGCTGTAGTTAAGAAATGTGACCAGAAGGGAACCAAACGAGCAGTGGCCACAAAGTTTGTGAACAAGAAGTTGATGAAGCGTGAC CAGGTCACTCATGAGCTTGGCATCCTGCAGAACCTCCAGCACCCCCTCTTCGTGAGCCTTCTAGACACCTTCGAGACCCCCACCAGTTACGTCCTGGTTTTGGAATTGGCTGACCAAGGTCGCCTCCT AGACTGTGTGGTACGATGGGGAAGTCTCACCGAAGGGAAGGTCAGAGCGCACCTGGGGGAAGTTCTGGAAGCCGTCCGATACCTTCACAACTGCAGGATAGCACACCTGGACCTAAAGCCTGAGAACA TCTTGGTGGATCAGAGTTTGGCCAAGCCAACCATTAAACTCACTGACTTTGGAGACGCTGTCCAGCTCAACACCACCTACTACATCCACCAGTTGCTGGGGAACCCCGAGTTTGCAGCCCCGGAAATC ATTCTTGGGAACCCTGTCTCCCTGACCGCGGACACGTGGAGCGTTGGGGTGCTCACGTACGTGCTGCTCAGCGGCGTGTCCCCCTTCTTGGATGACAGCGTGGAAGAGACCTGCCTGAACATTTGCCG ACTGGACTTCAGCTTCCCAGAGGACTACTTTCAAGGAGTTAGCCAGAAGGCCAAGGAATTCGTGTGCTTCCTCCTGCAGGAGGACCCCGCCAAGCGTCCCTCGGCTGCACTGGCCCTACAGGAGCAGT GGCTGCAGGCAGGTAACGGCAGCGGCAAAGGCATGGGCGTCCTCGACACGTCCAGACTGACCTCCTTCATTGAGCGGCGCAAACACCAGAATGATGTTCGACCTATCCGTAGCATTAAAAACTTCTTA CAGAGCAGGCTTCTGCCTAGAGTTTGACCTATCTTGAAGTTCTTTCTCATTCTCTTTCACCTGCCAATCAGCTGTTAATTTGAATTTTGAAGAGGAAACCAAACCAAACTAACTGGCCGGCCGCCGGC CGTTCATCGTGTGAAATGGCATTCCAAGTGAGCTGTGCTCGGCCGCGCTCGGGCTCAGAGCTGCACGCTGCACTGGGGTGGAGGACCTTCAGTTACGCTCTGCACAGGCAGAGATCACATTGCTGTAC CACAGTATCTTATTCAGGTTCCTGCAAAAAAATAAATAAATAAAGAGATACTTTTTTAAACGAACATGGATAGAATTTTGCAAATTTAACATTTTCAAGATTTATTCAAGGACACCTATGCCTATGTT CAGACCACTGGTGTTACACCAAACTGAGATACTGTGCATTTCTAGGAAAGACGAGTCAGGTGGTAGCCACTCCCATGGCCTCGGCCAGTGCTAGGCGTCCACGTGGCACTGAGCTTTTCCAACGGCCT CGTCTGGATACAACTTGCCGGGCACCAGACTTGGCTTCTGAAACGTGCATTCAACCTCAATCTTTTGCATAAAATGTAATGAATGGTTTTGCTCTGATGAAATGTAGGCCTTACTTGTACATAAGACT CTTCCTGCCTTTTGTCTGGCGTCCCCCATCCCTTCCCCTCCTACCCACCACCTGGGCCTTCCTCTCGGGGGTCTGATGGGGTCTGCCCATCCAATGGAGACTTTAGGCTGGGTCCAGTCCCACTGCCC CCTCCCTAGCCCCACCCCAAGCCGTCAATCAGATTGTTGAACGGTATACAGTCAGATGAAAATACTGTAAATGCACTCATTGGGGTTTTTTTTTTTTTTTTGGTTTTTTGTTTGTTTTGTTTTTTTTT TAATTTCATACCATGTGCAATGTTGTGACTTTAACATTTTCTGCAACTATTTATGAAGACTTCTGTTGTACCTGTAATAAATATATAGAAAAAGCACATTCTTCGCAAGTGAGCTTTATGGTTCTGTG TGTGTTGGGGGTGGGTCGTAGCCCTGTGCCATCAGTCAAGGATACTTAACTCTTCGTGAAATTTGTCAGCTTTGAGGACTGTAAAAAGTGATTTCATACTCTGAATATAAAACTGGATAATAGGGTAA TGTTTTAAATTTTATTATGCTATTATTCAGAATGCCAAAGTATTATTTTTTTCCCAGAAATCAGTCTGAACATTTACTACTTTTTAGACTTTTTGACATTCAACTTTCTGTATAAAAATAATTGGCTG GATTTTAAGCTTTTGGTAAGAAAGCCAATCAAGTACTGGCCGCCCCGAGGCTGGTGCACAGTGCCCGAGTCACGTGGCAGAGCTGGCTCTGGTGCGGGAAGTCCTTCACCACAGAAGTTGGATTTCTG GCACACTTGGATTTTTCTGGATGTCTTTTTACCTTTATTGTGTGAAATACACTAAAAAAGAGACCGGCTTGCTTCCCAAGGCAGCGAGACATCTGGGTCGTGAGCCATAAACGGGCATAACTCAGCTT TGCAGTTTCCAACGTATTTTATTTATTCTTCTGTTGGGTTTTTGTTTGTTTCTTTGTAAAATTGTACAGAAACTTTTTAAGAAAAATTGGATTCAAAAACTGGATGTGTATCTGTAACCTCATAACTT TTATTTGTGTACCGTCCCTTTGATTATTTCAGTTAAAAGTTTTTACATTATTTTTTTTGCATGTATATTTCTTTGTACAGAGACCTTACATGTTTACACAGTATGATGTGATGTAAATATTTTATTTT GCCATCAGTTATTTTAAGAAATTAAACATATTTGCCTGA
hide sequence
RefSeq Acc Id:
XM_006232091 ⟹ XP_006232153
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 80,235,485 - 80,531,127 (-) NCBI mRatBN7.2 2 78,505,069 - 78,800,738 (-) NCBI Rnor_6.0 2 80,473,202 - 80,767,997 (-) NCBI Rnor_5.0 2 100,137,355 - 100,437,964 (-) NCBI
Sequence:
TGTCATCCAGCCTTGGCGGTACAGTTCTGTGAAACCGGGCAGCCATCGCACCTTAGCCCAGGAA CCGAGGAAGGTGGCTGAGCTGAGGCGGCGGTCAGGTCCAGCCATTGTCTCTTGGGGGAGGCCAGGGAAGGACATCTGGGACCGTGGTGGTTCTAGGGAGAGGCGTGGGACTAGGGCTGGCGAGCACTG CGTGGGTGGCGTGGACCTGGAGGCAGCTCGGGGCAGCTCGGGGTCCGCTCTGGCGAGCAGGAGGTGGCCGAGGAGGAGGCTAGCCCGGAGCCCAGCGGTCGGGAGGGGCGCTGGTGTGCGGCGCAGGG GGCGTGACGGGGCGTCCCGGGGACCCCGGTAACGGCACCTCCTCCAAGCCCGGCCCGGCCCAGATCCCGCGCGAGCCCGGCTAGCGTCCGCACGTCCCTGCGTGCCGTCCGGTTTGCTTGCGCGCCCG GGAGGCGGCGGAGGGCAGCGGCGGCGGTCGGGGGCCTGCAGCTCGGGGAGCAGTCCCTGGCGGGCCAGGCTTGGGAGTGAGGATGCAGGCTCCGCGCTGGAGAGCCGGAGAGGGCGGCCCAGGGTTTC GAAAAAATGATGAAATGAAAGCTATGGATGTTTTGCCCATCCTGAAGGAAAAAGTCGCCTACCTTTCAGGTGGCAGAGATAAGCGTGGAGGTCCCATATTAACGTTTCCAGCCCGCAGCAATCATGAT AGAATGCGGCAGGAGGACCTCAGGAGGCTCATCTCCTATTTAGCCTGCATTCCCAGCGAGGAAGTCTGCAAGCGAGGGTTCACGGTGATTGTGGACATGCGCGGCTCCAAGTGGGACTCCATCAAACC ACTGTTGAAGATCCTGCAGGAGTCCTTCCCCTGCTGCATCCACATCGCCCTGATAATCAAGCCCGACAACTTCTGGCAGAAACAGAGGACGAATTTTGGCAGTTCCAAATTTGAATTTGAGACAAATA TGGTCTCTTTAGAAGGCCTTACCAAAGTGGTTGACCCCTCCCAGCTAACCCCTGAGTTTGATGGCTGCCTAGAGTACAACCATGAGGAATGGATAGAAATCCGAGTAGCTTTTGAGGACTACATTAGC AATGCAGCCCACATGCTGTCCCGGCTAGAGGAACTTCAGGACGTCCTTGCAAAAAAGGAGTTACCTCAGGACCTAGAGGGGGCTCGGAACATGATTGACGAGCATTCTCAGCTGAAGAAGAAGGTGAT CAAGGCTCCCATCGAGGACTTGGACTTAGAGGGGCAGAAGCTGCTTCAGCGGATCCAGAGCAGCGAGAGTTTTCCCAAAAAGAACTCAGGCTCGGGCAATGCAGACCTGCAGAACCTCTTGCCCAAGG TGTCCACCATGCTTGACAGGCTGCACTCGACTCGGCAGCACCTGCACCAGATGTGGCACGTGAGGAAACTGAAGTTGGACCAGTGCTTCCAGCTGCGGCTGTTCGAACAGGATGCTGAGAAGATGTTT GACTGGATCACACACAACAAAGGCCTGTTTCTAAACAGCTACACGGAGATCGGGGCCAGCCACCCTCACGCCATGGAGCTTCAGACGCAGCACAATCACTTTGCTATGAACTGTATGAACGTGTATGT AAATATCAACCGCATAATGTCGGTGGCCAATCGCCTGGTGGAGTCGGGCCACTATGCCTCTCAGCAGATTAAGCAGATCGCCAATCAGCTGGAACAGGAGTGGAAAGCGTTCGCAGCGGCCTTGGACG AGCGCAGCACCTTGTTGGACATGTCCTCCATCTTTCATCAGAAGGCTGAGAAGTACATGAGCAATGTGGACTCGTGGTGTAAGGCCTGTGGTGAAGTAGACCTTCCCTCGGAGCTGCAGGACCTGGAA GATGCCATTCATCATCACCAGGGGATCTATGAGCACATCACCCTCGCTTACTCTGAGGTAAGCCAGGATGGGAAGTCTCTCCTTGATAAGCTCCAGCGCCCCCTGACCCCCGGCAGCTCTGATTCCCT CACGGCCTCTGCCAACTACTCCAAGGCGGTGCACCATGTCTTGGATGTCATCCACGAGGTCCTGCACCACCAGCGCCAGCTCGAGAACATCTGGCAGCACCGCAAGGTTCGGCTCCACCAGAGGCTGC AGCTCTGTGTCTTCCAGCAGGACGTTCAGCAGGTGCTGGACTGGATAGAGAACCACGGAGAAGCATTTCTGAGCAAACACACAGGCGTGGGCAAATCCCTTCACCGGGCCAGAGCTTTGCAGAAACGC CATGAGGACTTCGAGGAAGTTGCACAGAACACGTACACAAATGCAGATAAACTGCTAGAAGCAGCAGAGCAGCTGGCTCAGACTGGGGAATGTGACCCCGAAGAGATTTATCAGGCTGCCCATCAGCT TGAAGACCGGATACAAGACTTTGTTCGGCGAGTTGAACAGCGGAAGATCCTGCTGGACATGTCTGTGTCATTTCACACCCATGTAAAAGAGCTCTGGACATGGCTGGAGGAGCTGCAGAAGGAACTGC TGGACGACGTGTACGCCGAGTCGGTGGAGGCCGTCCAGGATCTCATCAAGAGATTCGGCCAGCAGCAGCAGACCACCCTGCAGGTGACAGTCAACGTGATCAAGGAAGGGGAGGACCTCATCCAGCAG CTGAGGGACTCTGCCATCTCCAGTAACAAGACGCCGCACAACAGCTCCATCAACCACATCGAGACGGTGCTGCAGCAGCTGGACGAGGCTCAGTCCCAGATGGAGGAGCTCTTCCAGGAACGCAAGAT CAAGCTGGAACTCTTCCTGCAGCTACGCATATTCGAGCGGGATGCCATCGACATCATCTCGGACCTTGAGTCTTGGAATGATGAACTTTCCCAGCAAATGAACGACTTCGATACAGAGGATCTGACGA TCGCTGAGCAGCGCCTGCAGCACCATGCGGACAAAGCCCTAACCATGAATAACTTGACTTTCGACGTCATCCACCAGGGACAGGATCTTCTGCAGTACGTCAATGAGGTCCAGGCCTCTGGTGTGGAG CTGCTTTGCGACAGAGATGTGGACATGGCCACTCGGGTTCAGGACCTCCTGGAGTTTCTTCACGAAAAGCAGCAGGAGTTGGATTTAGCGGCCGAGCAGCATCGGAAACACTTGGAGCAGTGTGTGCA GTTGCGCCACCTGCAGGCAGAAGTGAAGCAGGTACTGGGCTGGATCCGGAATGGAGAGTCCATGCTGAATGCTGGGCTCATCACGGCCAGCTCGCTGCAGGAGGCCGAGCAGCTGCAGAGAGAGCACG AGCAGTTCCAGCACGCTATTGAGAAAACACACCAGAGTGCACTGCAGGTGCAGCAGAAGGCGGAGGCCATGCTGCAGGCCAACCACTACGACATGGACATGATCCGTGACTGTGCAGAGAAGGTCGCC TCGCACTGGCAGCAGCTCATGCTCAAGATGGAAGACCGCCTCAAGCTCGTCAACGCCTCCGTCGCCTTCTACAAGACTTCTGAGCAGGTCTGCAGTGTTCTGGAGAGCCTGGAGCAGGAGTACAAGAG AGAGGAGGACTGGTGTGGTGGAGCCGACAAGCTGGGCCCCAATTCTGAGACTGACCACGTCACCCCAATGATTAGCAAGCACCTCGAACAGAAGGAAGCCTTCCTGAAGGCTTGCACACTGGCCAGGA GGAACGCAGATGTCTTCCTAAAATACCTACACAGGAACAGCGTGAGCATGCCGGGGATGGTGACACACATCAAAGCTCCAGAACAGCAAGTAAAAAATATCTTGAACGAACTCTTCCAGCGGGAAAAC AGGGTATTGCATTATTGGACCATGAGAAAAAGGCGGCTGGACCAGTGCCAGCAGTACGTGGTCTTTGAGAGGAGTGCCAAGCAGGCATTAGAATGGATCCACGACAATGGGGAGTTCTATCTTTCCAC ACATACCTCAACAGGGTCCAGCATTCAGCATACACAGGAGCTGTTGAAAGAACATGAAGAGTTTCAGATAACTGCCAAGCAAACCAAAGAGAGGGTGAAGCTATTGATACAGCTGGCTGATGGCTTTT GTGAAAAAGGGCATGCCCATGCAGCAGAAATTAAAAAATGTGTGACCGCAGTGGATAAGAGGTACAGAGATTTCTCTCTGCGCATGGAGAAGTACCGGACCTCTTTGGAGAAAGCCCTGGGGATTTCT TCAGATTCCAACAAATCGAGTAAAAGCCTGCAGTTGGACATCATCCCTGCCAGTATCCCCGGGTCAGAGGTGAAGCTTCGGGATGCTGCTCACGAACTCAATGAAGAGAAGCGCAAGTCTGCCCGCAG GAAAGAGTTCATAATGGCTGAGTTAATTCAAACCGAAAAGGCTTATGTAAGAGACCTTCGAGAATGTATGGATACCTACCTGTGGGAAATGACCAGCGGAGTGGAGGAGATCCCGCCCGGCATCGTCA ACAAGGAGCTCATCATCTTCGGGAACATGCAGGAGATCTACGAGTTCCATAACAACATCTTCCTGAAGGAGCTGGAGAAGTACGAGCAGCTCCCAGAGGACGTGGGGCACTGCTTTGTCACCTGGGCA GACAAGTTTCAGATGTATGTCACATACTGCAAAAATAAACCTGATTCTACGCAGCTGATCCTGGAACACGCAGGGTCCTACTTTGACGAGATCCAGCAGCGGCATGGGTTAGCCAATTCCATCTCTTC CTACCTGATCAAACCAGTTCAGCGAATAACAAAGTACCAGCTCCTTTTAAAAGAGCTGCTCACATGCTGTGAAGAAGGAAAGGGGGAGATTAAAGATGGCCTCGAGGTGATGCTCAGTGTGCCCAAGC GAGCCAATGATGCCATGCACCTCAGCATGCTGGAAGGGTTTGATGAAAACATTGAGTCTCAGGGAGAGCTCATCCTGCAGGAGTCCTTCCAAGTGTGGGACCCAAAAACCTTAATTCGGAAGGGTCGA GAACGCCATCTCTTCCTTTTTGAAATGTCCTTAGTGTTCAGTAAAGAAGTGAAAGACTCCAGCGGGAGAAGCAAGTACCTGTACAAAAGCAAGCTGTTTACCTCAGAGTTGGGTGTCACGGAACATGT TGAAGGAGATCCTTGCAAATTTGCACTGTGGGTGGGGAGGACACCAACTTCAGATAATAAAATTGTCCTTAAGGCCTCCAGTATCGAGAACAAACAGGACTGGATAAAGCACATCCGTGAGGTGATAC AGGAGAGGACGGTGCACCTGAGAGGAGCCCTGAAGGAGCCCATCCACATCCCCAAGACGGCTCCCGCAGCAAGGCAGAAGGGGAGGAGGGATGGAGAGGACCTGGACAGCCAAGGGGACGGCAGCAGC CAGCCCGACACCATTTCCATTGCCTCCCGGACATCACAGAACACACTGGACAGTGACAAGCTTTCTGGCGGCTGCGAGCTGACAGTGGTGATCCATGACTTCACAGCTTGCAACAGCAATGAGCTGAC CATCCGGCGAGGCCAGACAGTGGAGGTTCTCGAACGGCCTCACGACAAGCCCGACTGGTGTCTGGTGCGCACCACTGATAGGTCCCCTGCAGCTGAAGGCCTCGTGCCCTGTGGCTCACTGTGCATTG CCCACTCACGAAGTAGCATGGAGATGGAGGGCATCTTCAACCACAAAGACTCACTGTCCGTCTCCAGTAATGACGCCAGCCCACCGGCCTCTGTGGCCTCCCTTCAACCCCACATGATGGGAGCACAG AGTTCACCAGGTCCCAAGCGGCCGGGCAACACCCTGCGCAAGTGGCTCACAAGCCCCGTACGGCGGCTCAGCAGTGGCAAGGCCGATGGACATGCGAAGAAGCTGGCCCACAAGCACAAGAAGAGCAG GGAGGTCCGGAAGAGTGCGGACGCTGGATCACAGAAGGATTCAGATGACAGCGCTGCCACCCCACAGGATGAGACCATCGAAGAGAGAGGACGGAACGAGGGCCTCAGCAGTGGTACGCTGTCCAAAT CCTCGTCCTCGGGCATGCAGAGCTGCGGAGAAGAAGAAGGAGAGGAGGGCGCCGACGCTGTACCACTGCCTCCGCCCATGGCCATCCAGCAGCACAGCCTCCTTCAGCCAGACTCGCAGGATGACAAG GCCTCTTCGAGGTTATTAGTCCGCCCCACCAGCTCTGAGACTCCCAGTGCGGCTGAGCTCGTCAGTGCGATTGAAGAACTCGTGAAGAGCAAAATGGCGCTGGAGGACCGCCCTAGCTCACTGCTTGT TGACCAGGGAGACAGTAGCAGCCCGTCCTTCAATCCCTCAGACAATTCTCTCCTCTCATCCTCCTCGCCCATTGACGAGATGGAAGAAAGAAAATGCAGCCTCTCTCTAAAGAGAAGACACTATGTTT TGCAAGAATTAGTGGAGACAGAGCGAGACTATGTGCGGGACCTTGGATGTGTGGTTGAGGGCTACATGGCGCTGATGAAGGAAGACGGCGTTCCTGATGACATGAAGGGGAAAGACAAGATCGTGTTT GGCAACATCCATCAGATTTACGACTGGCACAGAGACTTTTTTTTAGGAGAGTTGGAGAAGTGCCTTGAAGATCCAGAAAAACTAGGATCCCTTTTTGTAAAACACGAGAGAAGGTTGCACATGTACAT AGTTTATTGTCAAAATAAACCAAAGTCTGAGCACATTGTCTCCGAGTACATCGACACCTTTTTTGAGGACTTAAAGCAGCGCCTGGGCCACAGACTGCAGCTCACTGATCTGTTGATCAAACCTGTGC AGAGAATCATGAAGTACCAGCTGCTCCTGAAGGACTTCCTCAAGTACTCAAAAAAAGCTAGCCTGGACACGTCCGAATTAGAGAAAGCTGTAGAGGTCATGTGCATAGTGCCGAAGCGCTGCAACGAC ATGATGAACGTCGGGCGGCTGCAAGGATTTGACGGTAAAATTGTTGCCCAGGGTAAACTGCTCTTACAGGACACATTCCTGGTCACAGACCAAGATGCAGGGCTTCTGCCCCGATGCAAAGAGAGGCG GGTTTTCCTCTTTGAACAGATTGTCATATTCAGCGAACCGCTTGATAAGAAAAAGGGCTTTTCCATGCCAGGATTTCTGTTCAAGAACAGTATCAAGGTGAGTTGCCTTTGCCTGGAGGAGAATGTGG AGAGCGATCCCTGTAAGTTTGCCCTGACATCCAGGACGGGCGATGCCGTGGAGACCTTCATTTTGCATTCATCCAGTCCAAGTGTCCGACAAACGTGGATCCATGAAATCAACCAAATCTTAGAAAAC CAGCGCAACTTTTTAAATGCCTTGACATCACCCATCGAGTACCAGAGGAACCATAGCGGGGGCGGCGGCAGTGGCAGCGGGGGCAGCAGCGGCGGGGGCGGGGGCAGCGGTGGCAGCGGGGCCTCCAG TGGAGGCAGCAGCAGCCATGGCAGTGGCCCCAGCAGCTGCAGCAGTGGCCCCAGCTCGAGCAGGAGCAGGCCCTCCAGGATCCCACAGCCTGTCAGACACCACCCCCCCATGCTGGTCTCCTCTGCAG CCTCAAGCCAGGCAGAGGCAGACAAGATGTCAGGTATGTCTGCTCCCAGCCCCTCACTGCCTACCCCCAGCAACAGCCTGGCCCTCGAGGCCAGCCTTGGCCAGCCCAGCAGGCTCCCCCTGAGTGGA GACTCCGAAGGTCATGAGCGAGAGACAGAACCCATTCCCAAGATGAAGGTGATGGAGAGCCCCCGGAAGGCCCTGGGGAGTACTTCCGGTACAAGCCAAGATGGAAACACCAAGGATGCCCGGGGGAA CCTGGGCCCGCTGCCTCTGGGCAAGACTAGGCCGGGGGCCGTCTCGCCGCTGAACTCTCCTCTCTCCACCACGTTCCCTTCTCCTTTTGGCAAGGAGGCCTTTCCTCCCAGCAGCCCCCTGCAGAAGG GGGGCTCCTTCTGGAGCTCCATTCCTGCTTCCCCTGCCAGCCGGCCAAGCTCCTTCACCTTCCCGGGGGACAGTGACTCCCTCCAGCGACAGACGCACCGCCATGCAGCCCCCAGCAAGGACACGGAC CGCATGAGCACGTGCTCCTCGGCCAGCGAGCAGTCCGTGCAGTCCACTCAGAGCAACGGGAGTGAAAGCAGCAGCAGTAGCAACATCTCCACCATGCTGGTGACACACGAGTACACGGCAGTGAAGGA GGATGAGATAAACGTCTATCAAGGAGAGGTCGTTCAAATTCTGGCCAGCAACCAGCAGAACATGTTTCTGGTGTTCCGAGCCGCCACTGACCAGTGCCCCGCAGCCGAGGGTTGGATTCCAGGCTTCG TCTTGGGCCATACGAGTGCAGTTATCATGGAGAACCCGGACGGGACTTTCAAGAAGTCAACATCTTGGCACACAGCACTCCGTTTAAGGAAGAAGTCTGAGAAGAAAGATAAAGACGGCAAAAGGGAC GGCAAGTTGGAGAACGGGTACAGGAAGCCACGAGAAGGGCTCAGTAACAAGGTATCTGTGAAGCTTCTCAACCCCAACTATATCTATGACGTTCCCCCAGAATTCGTTATCCCATTGAGCGAGGTCAC ATGTGAGACAGGGGAGACCGTTGTTTTTAGATGTCGTGTCTGTGGCCGCCCCAAGGCCTCAATCACCTGGAAGGGCCCTGAACACAACACTTTGAACAACGATGACCACTACAACATCTCCTACAGTG ACGTTGGGGAGGCCACTCTGAAGATCATTGGTGTGAGCACAGAAGATGATGGTGTCTACACCTGCATCGCTGTGAACGACATGGGTTCAGCCTCGTCTTCTGCCAGTCTGAGGGTTCTAGGTCCAGGG AGTGATGGGATCGTGGTGACCTGGAAGGACAACTTCGACGCCTTCTACAGTGAGGTGGCTGAGCTCGGCAGGGGCAGATTTGCTGTAGTTAAGAAATGTGACCAGAAGGGAACCAAACGAGCAGTGGC CACAAAGTTTGTGAACAAGAAGTTGATGAAGCGTGACCAGGTCACTCATGAGCTTGGCATCCTGCAGAACCTCCAGCACCCCCTCTTCGTGAGCCTTCTAGACACCTTCGAGACCCCCACCAGTTACG TCCTGGTTTTGGAATTGGCTGACCAAGGTCGCCTCCTAGACTGTGTGGTACGATGGGGAAGTCTCACCGAAGGGAAGGTCAGAGCGCACCTGGGGGAAGTTCTGGAAGCCGTCCGATACCTTCACAAC TGCAGGATAGCACACCTGGACCTAAAGCCTGAGAACATCTTGGTGGATCAGAGTTTGGCCAAGCCAACCATTAAACTCACTGACTTTGGAGACGCTGTCCAGCTCAACACCACCTACTACATCCACCA GTTGCTGGGGAACCCCGAGTTTGCAGCCCCGGAAATCATTCTTGGGAACCCTGTCTCCCTGACCGCGGACACGTGGAGCGTTGGGGTGCTCACGTACGTGCTGCTCAGCGGCGTGTCCCCCTTCTTGG ATGACAGCGTGGAAGAGACCTGCCTGAACATTTGCCGACTGGACTTCAGCTTCCCAGAGGACTACTTTCAAGGAGTTAGCCAGAAGGCCAAGGAATTCGTGTGCTTCCTCCTGCAGGAGGACCCCGCC AAGCGTCCCTCGGCTGCACTGGCCCTACAGGAGCAGTGGCTGCAGGCAGGTAACGGCAGCGGCAAAGGCATGGGCGTCCTCGACACGTCCAGACTGACCTCCTTCATTGAGCGGCGCAAACACCAGAA TGATGTTCGACCTATCCGTAGCATTAAAAACTTCTTACAGAGCAGGCTTCTGCCTAGAGTTTGA
hide sequence
RefSeq Acc Id:
XM_017591212 ⟹ XP_017446701
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 80,247,534 - 80,531,824 (-) NCBI mRatBN7.2 2 78,517,118 - 78,801,384 (-) NCBI Rnor_6.0 2 80,483,497 - 80,769,312 (-) NCBI
Sequence:
AGAATCCTGGCAGGGGGCGCAGTGCCGGCCTGGAAGGCCAGTGTGGGTCGGTCACACTTGTTCC TGCTCCTCCCAGGTTTGGAGCAGCCCTGGAGGAGGAGACCTGGCCAGCTCCACGTTTCTGCAGCCACTCCATTCCGCCCTCAGGGCTCCCAGGCGCGGCCCCGCCCCTCCATGATCCCGCCCACAACA GGCACCGCCCACCAGCCGAGCCCACGCTCCGGCCCCTAACGAAGCTCTCCGGAAATTCCCGAAGCCCCTCTTTTTCCTTCCTCTCCTTTCCCTGCTCTCCCTTTCCTTTCACCCGGACTCCCTCGGCC GTGATTTCTCCCTCCCCCTCCTTCCTTCCCCATCGGAAAGCAAGATGGAGGCTCGCTGCTGCCGCCGGCGTCCGTGATCGCGGAGCTTCTCCAGCCCCGGCCCCCGCCCTCGCGTGTCCGCGCCGCTG CCCGCGCCCCGGCCGGCCACACAGAGGCCGTGGCTCCGCGCGCCCGCCCCGCGCCAGGCTCGCGGTTCCCGGGCGGTGTCCTCGTCTATGTGGGCGCGCTCCTCGGGCCGAGCCGCCGCCGCCCGCCG CCCCGGGGCTGTGCGTCCGCGCGCCGGGCGCGGGCAGCTGGGTGTTCGGCGCCGTCAGGCCAGGCGCGGGCGGCTGGGTGCGCGGAGCTAGGGGCGCGGGGCCTGAGGCGGGCTCGTCCGCCGCCGAA GCCATGAGCGGCAGCAGCGGCGGTGCCACCGCCCCGGCCGCGTCCTCCGGCCCGGCGGCGGCGGCCAGCGCGGCGGGCTCCGGCTGCGGGGGCGGCGCCGGCGAGGGTGCCGAGGAGGCCGCCAAGGA CCTGGCCGACATCGCGGCCTTCTTTCGATCCGGGTTTCGAAAAAATGATGAAATGAAAGCTATGGATGTTTTGCCCATCCTGAAGGAAAAAGTCGCCTACCTTTCAGGTGGCAGAGATAAGCGTGGAG GTCCCATATTAACGTTTCCAGCCCGCAGCAATCATGATAGAATGCGGCAGGAGGACCTCAGGAGGCTCATCTCCTATTTAGCCTGCATTCCCAGCGAGGAAGTCTGCAAGCGAGGGTTCACGGTGATT GTGGACATGCGCGGCTCCAAGTGGGACTCCATCAAACCACTGTTGAAGATCCTGCAGGAGTCCTTCCCCTGCTGCATCCACATCGCCCTGATAATCAAGCCCGACAACTTCTGGCAGAAACAGAGGAC GAATTTTGGCAGTTCCAAATTTGAATTTGAGACAAATATGGTCTCTTTAGAAGGCCTTACCAAAGTGGTTGACCCCTCCCAGCTAACCCCTGAGTTTGATGGCTGCCTAGAGTACAACCATGAGGAAT GGATAGAAATCCGAGTAGCTTTTGAGGACTACATTAGCAATGCAGCCCACATGCTGTCCCGGCTAGAGGAACTTCAGGACGTCCTTGCAAAAAAGGAGTTACCTCAGGACCTAGAGGGGGCTCGGAAC ATGATTGACGAGCATTCTCAGCTGAAGAAGAAGGTGATCAAGGCTCCCATCGAGGACTTGGACTTAGAGGGGCAGAAGCTGCTTCAGCGGATCCAGAGCAGCGAGAGTTTTCCCAAAAAGAACTCAGG CTCGGGCAATGCAGACCTGCAGAACCTCTTGCCCAAGGTGTCCACCATGCTTGACAGGCTGCACTCGACTCGGCAGCACCTGCACCAGATGTGGCACGTGAGGAAACTGAAGTTGGACCAGTGCTTCC AGCTGCGGCTGTTCGAACAGGATGCTGAGAAGATGTTTGACTGGATCACACACAACAAAGGCCTGTTTCTAAACAGCTACACGGAGATCGGGGCCAGCCACCCTCACGCCATGGAGCTTCAGACGCAG CACAATCACTTTGCTATGAACTGTATGAACGTGTATGTAAATATCAACCGCATAATGTCGGTGGCCAATCGCCTGGTGGAGTCGGGCCACTATGCCTCTCAGCAGATTAAGCAGATCGCCAATCAGCT GGAACAGGAGTGGAAAGCGTTCGCAGCGGCCTTGGACGAGCGCAGCACCTTGTTGGACATGTCCTCCATCTTTCATCAGAAGGCTGAGAAGTACATGAGCAATGTGGACTCGTGGTGTAAGGCCTGTG GTGAAGTAGACCTTCCCTCGGAGCTGCAGGACCTGGAAGATGCCATTCATCATCACCAGGGGATCTATGAGCACATCACCCTCGCTTACTCTGAGGTAAGCCAGGATGGGAAGTCTCTCCTTGATAAG CTCCAGCGCCCCCTGACCCCCGGCAGCTCTGATTCCCTCACGGCCTCTGCCAACTACTCCAAGGCGGTGCACCATGTCTTGGATGTCATCCACGAGGTCCTGCACCACCAGCGCCAGCTCGAGAACAT CTGGCAGCACCGCAAGGTTCGGCTCCACCAGAGGCTGCAGCTCTGTGTCTTCCAGCAGGACGTTCAGCAGGTGCTGGACTGGATAGAGAACCACGGAGAAGCATTTCTGAGCAAACACACAGGCGTGG GCAAATCCCTTCACCGGGCCAGAGCTTTGCAGAAACGCCATGAGGACTTCGAGGAAGTTGCACAGAACACGTACACAAATGCAGATAAACTGCTAGAAGCAGCAGAGCAGCTGGCTCAGACTGGGGAA TGTGACCCCGAAGAGATTTATCAGGCTGCCCATCAGCTTGAAGACCGGATACAAGACTTTGTTCGGCGAGTTGAACAGCGGAAGATCCTGCTGGACATGTCTGTGTCATTTCACACCCATGTAAAAGA GCTCTGGACATGGCTGGAGGAGCTGCAGAAGGAACTGCTGGACGACGTGTACGCCGAGTCGGTGGAGGCCGTCCAGGATCTCATCAAGAGATTCGGCCAGCAGCAGCAGACCACCCTGCAGGTGACAG TCAACGTGATCAAGGAAGGGGAGGACCTCATCCAGCAGCTGAGGGACTCTGCCATCTCCAGTAACAAGACGCCGCACAACAGCTCCATCAACCACATCGAGACGGTGCTGCAGCAGCTGGACGAGGCT CAGTCCCAGATGGAGGAGCTCTTCCAGGAACGCAAGATCAAGCTGGAACTCTTCCTGCAGCTACGCATATTCGAGCGGGATGCCATCGACATCATCTCGGACCTTGAGTCTTGGAATGATGAACTTTC CCAGCAAATGAACGACTTCGATACAGAGGATCTGACGATCGCTGAGCAGCGCCTGCAGCACCATGCGGACAAAGCCCTAACCATGAATAACTTGACTTTCGACGTCATCCACCAGGGACAGGATCTTC TGCAGTACGTCAATGAGGTCCAGGCCTCTGGTGTGGAGCTGCTTTGCGACAGAGATGTGGACATGGCCACTCGGGTTCAGGACCTCCTGGAGTTTCTTCACGAAAAGCAGCAGGAGTTGGATTTAGCG GCCGAGCAGCATCGGAAACACTTGGAGCAGTGTGTGCAGTTGCGCCACCTGCAGGCAGAAGTGAAGCAGGTACTGGGCTGGATCCGGAATGGAGAGTCCATGCTGAATGCTGGGCTCATCACGGCCAG CTCGCTGCAGGAGGCCGAGCAGCTGCAGAGAGAGCACGAGCAGTTCCAGCACGCTATTGAGAAAACACACCAGAGTGCACTGCAGGTGCAGCAGAAGGCGGAGGCCATGCTGCAGGCCAACCACTACG ACATGGACATGATCCGTGACTGTGCAGAGAAGGTCGCCTCGCACTGGCAGCAGCTCATGCTCAAGATGGAAGACCGCCTCAAGCTCGTCAACGCCTCCGTCGCCTTCTACAAGACTTCTGAGCAGGTC TGCAGTGTTCTGGAGAGCCTGGAGCAGGAGTACAAGAGAGAGGAGGACTGGTGTGGTGGAGCCGACAAGCTGGGCCCCAATTCTGAGACTGACCACGTCACCCCAATGATTAGCAAGCACCTCGAACA GAAGGAAGCCTTCCTGAAGGCTTGCACACTGGCCAGGAGGAACGCAGATGTCTTCCTAAAATACCTACACAGGAACAGCGTGAGCATGCCGGGGATGGTGACACACATCAAAGCTCCAGAACAGCAAG TAAAAAATATCTTGAACGAACTCTTCCAGCGGGAAAACAGGGTATTGCATTATTGGACCATGAGAAAAAGGCGGCTGGACCAGTGCCAGCAGTACGTGGTCTTTGAGAGGAGTGCCAAGCAGGCATTA GAATGGATCCACGACAATGGGGAGTTCTATCTTTCCACACATACCTCAACAGGGTCCAGCATTCAGCATACACAGGAGCTGTTGAAAGAACATGAAGAGTTTCAGATAACTGCCAAGCAAACCAAAGA GAGGGTGAAGCTATTGATACAGCTGGCTGATGGCTTTTGTGAAAAAGGGCATGCCCATGCAGCAGAAATTAAAAAATGTGTGACCGCAGTGGATAAGAGGTACAGAGATTTCTCTCTGCGCATGGAGA AGTACCGGACCTCTTTGGAGAAAGCCCTGGGGATTTCTTCAGATTCCAACAAATCGAGTAAAAGCCTGCAGTTGGACATCATCCCTGCCAGTATCCCCGGGTCAGAGGTGAAGCTTCGGGATGCTGCT CACGAACTCAATGAAGAGAAGCGCAAGTCTGCCCGCAGGAAAGAGTTCATAATGGCTGAGTTAATTCAAACCGAAAAGGCTTATGTAAGAGACCTTCGAGAATGTATGGATACCTACCTGTGGGAAAT GACCAGCGGAGTGGAGGAGATCCCGCCCGGCATCGTCAACAAGGAGCTCATCATCTTCGGGAACATGCAGGAGATCTACGAGTTCCATAACAACATCTTCCTGAAGGAGCTGGAGAAGTACGAGCAGC TCCCAGAGGACGTGGGGCACTGCTTTGTCACCTGGGCAGACAAGTTTCAGATGTATGTCACATACTGCAAAAATAAACCTGATTCTACGCAGCTGATCCTGGAACACGCAGGGTCCTACTTTGACGAG ATCCAGCAGCGGCATGGGTTAGCCAATTCCATCTCTTCCTACCTGATCAAACCAGTTCAGCGAATAACAAAGTACCAGCTCCTTTTAAAAGAGCTGCTCACATGCTGTGAAGAAGGAAAGGGGGAGAT TAAAGATGGCCTCGAGGTGATGCTCAGTGTGCCCAAGCGAGCCAATGATGCCATGCACCTCAGCATGCTGGAAGGGTTTGATGAAAACATTGAGTCTCAGGGAGAGCTCATCCTGCAGGAGTCCTTCC AAGTGTGGGACCCAAAAACCTTAATTCGGAAGGGTCGAGAACGCCATCTCTTCCTTTTTGAAATGTCCTTAGTGTTCAGTAAAGAAGTGAAAGACTCCAGCGGGAGAAGCAAGTACCTGTACAAAAGC AAGCTGTTTACCTCAGAGTTGGGTGTCACGGAACATGTTGAAGGAGATCCTTGCAAATTTGCACTGTGGGTGGGGAGGACACCAACTTCAGATAATAAAATTGTCCTTAAGGCCTCCAGTATCGAGAA CAAACAGGACTGGATAAAGCACATCCGTGAGGTGATACAGGAGAGGACGGTGCACCTGAGAGGAGCCCTGAAGGAGCCCATCCACATCCCCAAGACGGCTCCCGCAGCAAGGCAGAAGGGGAGGAGGG ATGGAGAGGACCTGGACAGCCAAGGGGACGGCAGCAGCCAGCCCGACACCATTTCCATTGCCTCCCGGACATCACAGAACACACTGGACAGTGACAAGCTTTCTGGCGGCTGCGAGCTGACAGTGGTG ATCCATGACTTCACAGCTTGCAACAGCAATGAGCTGACCATCCGGCGAGGCCAGACAGTGGAGGTTCTCGAACGGCCTCACGACAAGCCCGACTGGTGTCTGGTGCGCACCACTGATAGGTCCCCTGC AGCTGAAGGCCTCGTGCCCTGTGGCTCACTGTGCATTGCCCACTCACGAAGTAGCATGGAGATGGAGGGCATCTTCAACCACAAAGACTCACTGTCCGTCTCCAGTAATGACGCCAGCCCACCGGCCT CTGTGGCCTCCCTTCAACCCCACATGATGGGAGCACAGAGTTCACCAGGTCCCAAGCGGCCGGGCAACACCCTGCGCAAGTGGCTCACAAGCCCCGTACGGCGGCTCAGCAGTGGCAAGGCCGATGGA CATGCGAAGAAGCTGGCCCACAAGCACAAGAAGAGCAGGGAGGTCCGGAAGAGTGCGGACGCTGGATCACAGAAGGATTCAGATGACAGCGCTGCCACCCCACAGGATGAGACCATCGAAGAGAGAGG ACGGAACGAGGGCCTCAGCAGTGGTACGCTGTCCAAATCCTCGTCCTCGGGCATGCAGAGCTGCGGAGAAGAAGAAGGAGAGGAGGGCGCCGACGCTGTACCACTGCCTCCGCCCATGGCCATCCAGC AGCACAGCCTCCTTCAGCCAGACTCGCAGGATGACAAGGCCTCTTCGAGGTTATTAGTCCGCCCCACCAGCTCTGAGACTCCCAGTGCGGCTGAGCTCGTCAGTGCGATTGAAGAACTCGTGAAGAGC AAAATGGCGCTGGAGGACCGCCCTAGCTCACTGCTTGTTGACCAGGGAGACAGTAGCAGCCCGTCCTTCAATCCCTCAGACAATTCTCTCCTCTCATCCTCCTCGCCCATTGACGAGATGGAAGAAAG AAAATGCAGCCTCTCTCTAAAGAGAAGACACTATGTTTTGCAAGAATTAGTGGAGACAGAGCGAGACTATGTGCGGGACCTTGGATGTGTGGTTGAGGGCTACATGGCGCTGATGAAGGAAGACGGCG TTCCTGATGACATGAAGGGGAAAGACAAGATCGTGTTTGGCAACATCCATCAGATTTACGACTGGCACAGAGACTTTTTTTTAGGAGAGTTGGAGAAGTGCCTTGAAGATCCAGAAAAACTAGGATCC CTTTTTGTAAAACACGAGAGAAGGTTGCACATGTACATAGTTTATTGTCAAAATAAACCAAAGTCTGAGCACATTGTCTCCGAGTACATCGACACCTTTTTTGAGGACTTAAAGCAGCGCCTGGGCCA CAGACTGCAGCTCACTGATCTGTTGATCAAACCTGTGCAGAGAATCATGAAGTACCAGCTGCTCCTGAAGGACTTCCTCAAGTACTCAAAAAAAGCTAGCCTGGACACGTCCGAATTAGAGAAAGCTG TAGAGGTCATGTGCATAGTGCCGAAGCGCTGCAACGACATGATGAACGTCGGGCGGCTGCAAGGATTTGACGGTAAAATTGTTGCCCAGGGTAAACTGCTCTTACAGGACACATTCCTGGTCACAGAC CAAGATGCAGGGCTTCTGCCCCGATGCAAAGAGAGGCGGGTTTTCCTCTTTGAACAGATTGTCATATTCAGCGAACCGCTTGATAAGAAAAAGGGCTTTTCCATGCCAGGATTTCTGTTCAAGAACAG TATCAAGGTGAGTTGCCTTTGCCTGGAGGAGAATGTGGAGAGCGATCCCTGTAAGTTTGCCCTGACATCCAGGACGGGCGATGCCGTGGAGACCTTCATTTTGCATTCATCCAGTCCAAGTGTCCGAC AAACGTGGATCCATGAAATCAACCAAATCTTAGAAAACCAGCGCAACTTTTTAAATGCCTTGACATCACCCATCGAGTACCAGAGGAACCATAGCGGGGGCGGCGGCAGTGGCAGCGGGGGCAGCAGC GGCGGGGGCGGGGGCAGCGGTGGCAGCGGGGCCTCCAGTGGAGGCAGCAGCAGCCATGGCAGTGGCCCCAGCAGCTGCAGCAGTGGCCCCAGCTCGAGCAGGAGCAGGCCCTCCAGGATCCCACAGCC TGTCAGACACCACCCCCCCATGCTGGTCTCCTCTGCAGCCTCAAGCCAGGCAGAGGCAGACAAGATGTCAGAGTGAAAGCAGCAGCAGTAGCAACATCTCCACCATGCTGGTGACACACGAGTACACG GCAGTGAAGGAGGATGAGATAAACGTCTAT
hide sequence
RefSeq Acc Id:
XM_039102226 ⟹ XP_038958154
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 80,235,485 - 80,380,061 (-) NCBI mRatBN7.2 2 78,505,069 - 78,649,651 (-) NCBI
RefSeq Acc Id:
XP_006232152 ⟸ XM_006232090
- Peptide Label:
isoform X1
- UniProtKB:
F1M0Z1 (UniProtKB/Swiss-Prot)
- Sequence:
MSGSSGGATAPAASSGPAAAASAAGSGCGGGAGEGAEEAAKDLADIAAFFRSGFRKNDEMKAMDVLPILKEKVAYLSGGRDKRGGPILTFPARSNHDRMRQEDLRRLISYLACIPSEEVCKRGFTVIV DMRGSKWDSIKPLLKILQESFPCCIHIALIIKPDNFWQKQRTNFGSSKFEFETNMVSLEGLTKVVDPSQLTPEFDGCLEYNHEEWIEIRVAFEDYISNAAHMLSRLEELQDVLAKKELPQDLEGARNM IDEHSQLKKKVIKAPIEDLDLEGQKLLQRIQSSESFPKKNSGSGNADLQNLLPKVSTMLDRLHSTRQHLHQMWHVRKLKLDQCFQLRLFEQDAEKMFDWITHNKGLFLNSYTEIGASHPHAMELQTQH NHFAMNCMNVYVNINRIMSVANRLVESGHYASQQIKQIANQLEQEWKAFAAALDERSTLLDMSSIFHQKAEKYMSNVDSWCKACGEVDLPSELQDLEDAIHHHQGIYEHITLAYSEVSQDGKSLLDKL QRPLTPGSSDSLTASANYSKAVHHVLDVIHEVLHHQRQLENIWQHRKVRLHQRLQLCVFQQDVQQVLDWIENHGEAFLSKHTGVGKSLHRARALQKRHEDFEEVAQNTYTNADKLLEAAEQLAQTGEC DPEEIYQAAHQLEDRIQDFVRRVEQRKILLDMSVSFHTHVKELWTWLEELQKELLDDVYAESVEAVQDLIKRFGQQQQTTLQVTVNVIKEGEDLIQQLRDSAISSNKTPHNSSINHIETVLQQLDEAQ SQMEELFQERKIKLELFLQLRIFERDAIDIISDLESWNDELSQQMNDFDTEDLTIAEQRLQHHADKALTMNNLTFDVIHQGQDLLQYVNEVQASGVELLCDRDVDMATRVQDLLEFLHEKQQELDLAA EQHRKHLEQCVQLRHLQAEVKQVLGWIRNGESMLNAGLITASSLQEAEQLQREHEQFQHAIEKTHQSALQVQQKAEAMLQANHYDMDMIRDCAEKVASHWQQLMLKMEDRLKLVNASVAFYKTSEQVC SVLESLEQEYKREEDWCGGADKLGPNSETDHVTPMISKHLEQKEAFLKACTLARRNADVFLKYLHRNSVSMPGMVTHIKAPEQQVKNILNELFQRENRVLHYWTMRKRRLDQCQQYVVFERSAKQALE WIHDNGEFYLSTHTSTGSSIQHTQELLKEHEEFQITAKQTKERVKLLIQLADGFCEKGHAHAAEIKKCVTAVDKRYRDFSLRMEKYRTSLEKALGISSDSNKSSKSLQLDIIPASIPGSEVKLRDAAH ELNEEKRKSARRKEFIMAELIQTEKAYVRDLRECMDTYLWEMTSGVEEIPPGIVNKELIIFGNMQEIYEFHNNIFLKELEKYEQLPEDVGHCFVTWADKFQMYVTYCKNKPDSTQLILEHAGSYFDEI QQRHGLANSISSYLIKPVQRITKYQLLLKELLTCCEEGKGEIKDGLEVMLSVPKRANDAMHLSMLEGFDENIESQGELILQESFQVWDPKTLIRKGRERHLFLFEMSLVFSKEVKDSSGRSKYLYKSK LFTSELGVTEHVEGDPCKFALWVGRTPTSDNKIVLKASSIENKQDWIKHIREVIQERTVHLRGALKEPIHIPKTAPAARQKGRRDGEDLDSQGDGSSQPDTISIASRTSQNTLDSDKLSGGCELTVVI HDFTACNSNELTIRRGQTVEVLERPHDKPDWCLVRTTDRSPAAEGLVPCGSLCIAHSRSSMEMEGIFNHKDSLSVSSNDASPPASVASLQPHMMGAQSSPGPKRPGNTLRKWLTSPVRRLSSGKADGH AKKLAHKHKKSREVRKSADAGSQKDSDDSAATPQDETIEERGRNEGLSSGTLSKSSSSGMQSCGEEEGEEGADAVPLPPPMAIQQHSLLQPDSQDDKASSRLLVRPTSSETPSAAELVSAIEELVKSK MALEDRPSSLLVDQGDSSSPSFNPSDNSLLSSSSPIDEMEERKCSLSLKRRHYVLQELVETERDYVRDLGCVVEGYMALMKEDGVPDDMKGKDKIVFGNIHQIYDWHRDFFLGELEKCLEDPEKLGSL FVKHERRLHMYIVYCQNKPKSEHIVSEYIDTFFEDLKQRLGHRLQLTDLLIKPVQRIMKYQLLLKDFLKYSKKASLDTSELEKAVEVMCIVPKRCNDMMNVGRLQGFDGKIVAQGKLLLQDTFLVTDQ DAGLLPRCKERRVFLFEQIVIFSEPLDKKKGFSMPGFLFKNSIKVSCLCLEENVESDPCKFALTSRTGDAVETFILHSSSPSVRQTWIHEINQILENQRNFLNALTSPIEYQRNHSGGGGSGSGGSSG GGGGSGGSGASSGGSSSHGSGPSSCSSGPSSSRSRPSRIPQPVRHHPPMLVSSAASSQAEADKMSGMSAPSPSLPTPSNSLALEASLGQPSRLPLSGDSEGHERETEPIPKMKVMESPRKALGSTSGT SQDGNTKDARGNLGPLPLGKTRPGAVSPLNSPLSTTFPSPFGKEAFPPSSPLQKGGSFWSSIPASPASRPSSFTFPGDSDSLQRQTHRHAAPSKDTDRMSTCSSASEQSVQSTQSNGSESSSSSNIST MLVTHEYTAVKEDEINVYQGEVVQILASNQQNMFLVFRAATDQCPAAEGWIPGFVLGHTSAVIMENPDGTFKKSTSWHTALRLRKKSEKKDKDGKRDGKLENGYRKPREGLSNKLLNPNYIYDVPPEF VIPLSEVTCETGETVVFRCRVCGRPKASITWKGPEHNTLNNDDHYNISYSDVGEATLKIIGVSTEDDGVYTCIAVNDMGSASSSASLRVLGPGSDGIVVTWKDNFDAFYSEVAELGRGRFAVVKKCDQ KGTKRAVATKFVNKKLMKRDQVTHELGILQNLQHPLFVSLLDTFETPTSYVLVLELADQGRLLDCVVRWGSLTEGKVRAHLGEVLEAVRYLHNCRIAHLDLKPENILVDQSLAKPTIKLTDFGDAVQL NTTYYIHQLLGNPEFAAPEIILGNPVSLTADTWSVGVLTYVLLSGVSPFLDDSVEETCLNICRLDFSFPEDYFQGVSQKAKEFVCFLLQEDPAKRPSAALALQEQWLQAGNGSGKGMGVLDTSRLTSF IERRKHQNDVRPIRSIKNFLQSRLLPRV
hide sequence
RefSeq Acc Id:
XP_006232153 ⟸ XM_006232091
- Peptide Label:
isoform X2
- UniProtKB:
A0A1P0PBZ6 (UniProtKB/TrEMBL)
- Sequence:
MQAPRWRAGEGGPGFRKNDEMKAMDVLPILKEKVAYLSGGRDKRGGPILTFPARSNHDRMRQED LRRLISYLACIPSEEVCKRGFTVIVDMRGSKWDSIKPLLKILQESFPCCIHIALIIKPDNFWQKQRTNFGSSKFEFETNMVSLEGLTKVVDPSQLTPEFDGCLEYNHEEWIEIRVAFEDYISNAAHML SRLEELQDVLAKKELPQDLEGARNMIDEHSQLKKKVIKAPIEDLDLEGQKLLQRIQSSESFPKKNSGSGNADLQNLLPKVSTMLDRLHSTRQHLHQMWHVRKLKLDQCFQLRLFEQDAEKMFDWITHN KGLFLNSYTEIGASHPHAMELQTQHNHFAMNCMNVYVNINRIMSVANRLVESGHYASQQIKQIANQLEQEWKAFAAALDERSTLLDMSSIFHQKAEKYMSNVDSWCKACGEVDLPSELQDLEDAIHHH QGIYEHITLAYSEVSQDGKSLLDKLQRPLTPGSSDSLTASANYSKAVHHVLDVIHEVLHHQRQLENIWQHRKVRLHQRLQLCVFQQDVQQVLDWIENHGEAFLSKHTGVGKSLHRARALQKRHEDFEE VAQNTYTNADKLLEAAEQLAQTGECDPEEIYQAAHQLEDRIQDFVRRVEQRKILLDMSVSFHTHVKELWTWLEELQKELLDDVYAESVEAVQDLIKRFGQQQQTTLQVTVNVIKEGEDLIQQLRDSAI SSNKTPHNSSINHIETVLQQLDEAQSQMEELFQERKIKLELFLQLRIFERDAIDIISDLESWNDELSQQMNDFDTEDLTIAEQRLQHHADKALTMNNLTFDVIHQGQDLLQYVNEVQASGVELLCDRD VDMATRVQDLLEFLHEKQQELDLAAEQHRKHLEQCVQLRHLQAEVKQVLGWIRNGESMLNAGLITASSLQEAEQLQREHEQFQHAIEKTHQSALQVQQKAEAMLQANHYDMDMIRDCAEKVASHWQQL MLKMEDRLKLVNASVAFYKTSEQVCSVLESLEQEYKREEDWCGGADKLGPNSETDHVTPMISKHLEQKEAFLKACTLARRNADVFLKYLHRNSVSMPGMVTHIKAPEQQVKNILNELFQRENRVLHYW TMRKRRLDQCQQYVVFERSAKQALEWIHDNGEFYLSTHTSTGSSIQHTQELLKEHEEFQITAKQTKERVKLLIQLADGFCEKGHAHAAEIKKCVTAVDKRYRDFSLRMEKYRTSLEKALGISSDSNKS SKSLQLDIIPASIPGSEVKLRDAAHELNEEKRKSARRKEFIMAELIQTEKAYVRDLRECMDTYLWEMTSGVEEIPPGIVNKELIIFGNMQEIYEFHNNIFLKELEKYEQLPEDVGHCFVTWADKFQMY VTYCKNKPDSTQLILEHAGSYFDEIQQRHGLANSISSYLIKPVQRITKYQLLLKELLTCCEEGKGEIKDGLEVMLSVPKRANDAMHLSMLEGFDENIESQGELILQESFQVWDPKTLIRKGRERHLFL FEMSLVFSKEVKDSSGRSKYLYKSKLFTSELGVTEHVEGDPCKFALWVGRTPTSDNKIVLKASSIENKQDWIKHIREVIQERTVHLRGALKEPIHIPKTAPAARQKGRRDGEDLDSQGDGSSQPDTIS IASRTSQNTLDSDKLSGGCELTVVIHDFTACNSNELTIRRGQTVEVLERPHDKPDWCLVRTTDRSPAAEGLVPCGSLCIAHSRSSMEMEGIFNHKDSLSVSSNDASPPASVASLQPHMMGAQSSPGPK RPGNTLRKWLTSPVRRLSSGKADGHAKKLAHKHKKSREVRKSADAGSQKDSDDSAATPQDETIEERGRNEGLSSGTLSKSSSSGMQSCGEEEGEEGADAVPLPPPMAIQQHSLLQPDSQDDKASSRLL VRPTSSETPSAAELVSAIEELVKSKMALEDRPSSLLVDQGDSSSPSFNPSDNSLLSSSSPIDEMEERKCSLSLKRRHYVLQELVETERDYVRDLGCVVEGYMALMKEDGVPDDMKGKDKIVFGNIHQI YDWHRDFFLGELEKCLEDPEKLGSLFVKHERRLHMYIVYCQNKPKSEHIVSEYIDTFFEDLKQRLGHRLQLTDLLIKPVQRIMKYQLLLKDFLKYSKKASLDTSELEKAVEVMCIVPKRCNDMMNVGR LQGFDGKIVAQGKLLLQDTFLVTDQDAGLLPRCKERRVFLFEQIVIFSEPLDKKKGFSMPGFLFKNSIKVSCLCLEENVESDPCKFALTSRTGDAVETFILHSSSPSVRQTWIHEINQILENQRNFLN ALTSPIEYQRNHSGGGGSGSGGSSGGGGGSGGSGASSGGSSSHGSGPSSCSSGPSSSRSRPSRIPQPVRHHPPMLVSSAASSQAEADKMSGMSAPSPSLPTPSNSLALEASLGQPSRLPLSGDSEGHE RETEPIPKMKVMESPRKALGSTSGTSQDGNTKDARGNLGPLPLGKTRPGAVSPLNSPLSTTFPSPFGKEAFPPSSPLQKGGSFWSSIPASPASRPSSFTFPGDSDSLQRQTHRHAAPSKDTDRMSTCS SASEQSVQSTQSNGSESSSSSNISTMLVTHEYTAVKEDEINVYQGEVVQILASNQQNMFLVFRAATDQCPAAEGWIPGFVLGHTSAVIMENPDGTFKKSTSWHTALRLRKKSEKKDKDGKRDGKLENG YRKPREGLSNKVSVKLLNPNYIYDVPPEFVIPLSEVTCETGETVVFRCRVCGRPKASITWKGPEHNTLNNDDHYNISYSDVGEATLKIIGVSTEDDGVYTCIAVNDMGSASSSASLRVLGPGSDGIVV TWKDNFDAFYSEVAELGRGRFAVVKKCDQKGTKRAVATKFVNKKLMKRDQVTHELGILQNLQHPLFVSLLDTFETPTSYVLVLELADQGRLLDCVVRWGSLTEGKVRAHLGEVLEAVRYLHNCRIAHL DLKPENILVDQSLAKPTIKLTDFGDAVQLNTTYYIHQLLGNPEFAAPEIILGNPVSLTADTWSVGVLTYVLLSGVSPFLDDSVEETCLNICRLDFSFPEDYFQGVSQKAKEFVCFLLQEDPAKRPSAA LALQEQWLQAGNGSGKGMGVLDTSRLTSFIERRKHQNDVRPIRSIKNFLQSRLLPRV
hide sequence
RefSeq Acc Id:
XP_017446701 ⟸ XM_017591212
- Peptide Label:
isoform X4
- Sequence:
MSGSSGGATAPAASSGPAAAASAAGSGCGGGAGEGAEEAAKDLADIAAFFRSGFRKNDEMKAMD VLPILKEKVAYLSGGRDKRGGPILTFPARSNHDRMRQEDLRRLISYLACIPSEEVCKRGFTVIVDMRGSKWDSIKPLLKILQESFPCCIHIALIIKPDNFWQKQRTNFGSSKFEFETNMVSLEGLTKV VDPSQLTPEFDGCLEYNHEEWIEIRVAFEDYISNAAHMLSRLEELQDVLAKKELPQDLEGARNMIDEHSQLKKKVIKAPIEDLDLEGQKLLQRIQSSESFPKKNSGSGNADLQNLLPKVSTMLDRLHS TRQHLHQMWHVRKLKLDQCFQLRLFEQDAEKMFDWITHNKGLFLNSYTEIGASHPHAMELQTQHNHFAMNCMNVYVNINRIMSVANRLVESGHYASQQIKQIANQLEQEWKAFAAALDERSTLLDMSS IFHQKAEKYMSNVDSWCKACGEVDLPSELQDLEDAIHHHQGIYEHITLAYSEVSQDGKSLLDKLQRPLTPGSSDSLTASANYSKAVHHVLDVIHEVLHHQRQLENIWQHRKVRLHQRLQLCVFQQDVQ QVLDWIENHGEAFLSKHTGVGKSLHRARALQKRHEDFEEVAQNTYTNADKLLEAAEQLAQTGECDPEEIYQAAHQLEDRIQDFVRRVEQRKILLDMSVSFHTHVKELWTWLEELQKELLDDVYAESVE AVQDLIKRFGQQQQTTLQVTVNVIKEGEDLIQQLRDSAISSNKTPHNSSINHIETVLQQLDEAQSQMEELFQERKIKLELFLQLRIFERDAIDIISDLESWNDELSQQMNDFDTEDLTIAEQRLQHHA DKALTMNNLTFDVIHQGQDLLQYVNEVQASGVELLCDRDVDMATRVQDLLEFLHEKQQELDLAAEQHRKHLEQCVQLRHLQAEVKQVLGWIRNGESMLNAGLITASSLQEAEQLQREHEQFQHAIEKT HQSALQVQQKAEAMLQANHYDMDMIRDCAEKVASHWQQLMLKMEDRLKLVNASVAFYKTSEQVCSVLESLEQEYKREEDWCGGADKLGPNSETDHVTPMISKHLEQKEAFLKACTLARRNADVFLKYL HRNSVSMPGMVTHIKAPEQQVKNILNELFQRENRVLHYWTMRKRRLDQCQQYVVFERSAKQALEWIHDNGEFYLSTHTSTGSSIQHTQELLKEHEEFQITAKQTKERVKLLIQLADGFCEKGHAHAAE IKKCVTAVDKRYRDFSLRMEKYRTSLEKALGISSDSNKSSKSLQLDIIPASIPGSEVKLRDAAHELNEEKRKSARRKEFIMAELIQTEKAYVRDLRECMDTYLWEMTSGVEEIPPGIVNKELIIFGNM QEIYEFHNNIFLKELEKYEQLPEDVGHCFVTWADKFQMYVTYCKNKPDSTQLILEHAGSYFDEIQQRHGLANSISSYLIKPVQRITKYQLLLKELLTCCEEGKGEIKDGLEVMLSVPKRANDAMHLSM LEGFDENIESQGELILQESFQVWDPKTLIRKGRERHLFLFEMSLVFSKEVKDSSGRSKYLYKSKLFTSELGVTEHVEGDPCKFALWVGRTPTSDNKIVLKASSIENKQDWIKHIREVIQERTVHLRGA LKEPIHIPKTAPAARQKGRRDGEDLDSQGDGSSQPDTISIASRTSQNTLDSDKLSGGCELTVVIHDFTACNSNELTIRRGQTVEVLERPHDKPDWCLVRTTDRSPAAEGLVPCGSLCIAHSRSSMEME GIFNHKDSLSVSSNDASPPASVASLQPHMMGAQSSPGPKRPGNTLRKWLTSPVRRLSSGKADGHAKKLAHKHKKSREVRKSADAGSQKDSDDSAATPQDETIEERGRNEGLSSGTLSKSSSSGMQSCG EEEGEEGADAVPLPPPMAIQQHSLLQPDSQDDKASSRLLVRPTSSETPSAAELVSAIEELVKSKMALEDRPSSLLVDQGDSSSPSFNPSDNSLLSSSSPIDEMEERKCSLSLKRRHYVLQELVETERD YVRDLGCVVEGYMALMKEDGVPDDMKGKDKIVFGNIHQIYDWHRDFFLGELEKCLEDPEKLGSLFVKHERRLHMYIVYCQNKPKSEHIVSEYIDTFFEDLKQRLGHRLQLTDLLIKPVQRIMKYQLLL KDFLKYSKKASLDTSELEKAVEVMCIVPKRCNDMMNVGRLQGFDGKIVAQGKLLLQDTFLVTDQDAGLLPRCKERRVFLFEQIVIFSEPLDKKKGFSMPGFLFKNSIKVSCLCLEENVESDPCKFALT SRTGDAVETFILHSSSPSVRQTWIHEINQILENQRNFLNALTSPIEYQRNHSGGGGSGSGGSSGGGGGSGGSGASSGGSSSHGSGPSSCSSGPSSSRSRPSRIPQPVRHHPPMLVSSAASSQAEADKM SE
hide sequence
Ensembl Acc Id:
ENSRNOP00000016784 ⟸ ENSRNOT00000016784
RefSeq Acc Id:
NP_001101128 ⟸ NM_001107658
- UniProtKB:
F1M0Z1 (UniProtKB/Swiss-Prot), A0A8I6AS57 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038958154 ⟸ XM_039102226
- Peptide Label:
isoform X3
Ensembl Acc Id:
ENSRNOP00000091530 ⟸ ENSRNOT00000093833
Ensembl Acc Id:
ENSRNOP00000081265 ⟸ ENSRNOT00000099604
Ensembl Acc Id:
ENSRNOP00000076435 ⟸ ENSRNOT00000107418
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2013-08-02
Trio
trio Rho guanine nucleotide exchange factor
Trio
triple functional domain (PTPRF interacting)
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2005-12-06
Trio
triple functional domain (PTPRF interacting)
Trio_predicted
triple functional domain (PTPRF interacting) (predicted)
Symbol and Name updated
1559027
APPROVED
2005-01-12
Trio_predicted
triple functional domain (PTPRF interacting) (predicted)
Symbol and Name status set to approved
70820
APPROVED